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Chapter 1 General introduction 
The heart, an important organ of the mammalian, operates as a pump. It is composed 
of two pumps: the right heart pumps the blood through the lungs while the left heart 
pumps the blood through peripheral organs. In turn, each of these separate pumps are 
composed of two pulsatile chambers, an atrium and a ventricle. Each minute, the heart of 
a resting adult pumps about 5 L of blood, or approximately the person's total blood 
volume. This works out to at least 720 Llday, the volume of blood weighting about 100 
times more than the body. This heavy and incessant work is based on the fact that the 
heart muscle has a coordinated contraction. The cardiac muscle fibres are highly organized 
with strong inter-connections. A trigger pulse from the sinoatrial node, being the 
pacemaker, initiates and coordinates contraction, making possible the function of the heart 
as a pump and the contractility as the major parameter of the function of the heart. 
1.1 Myocardial contraction 
Since the effccts on cardiac contractility are associated with changes in cellular 
mechanisms, the foHowing brief review can be helpful to understand the mechanisms of 
actions of the inotropic agents. 
The heart muscle cells are excitable, with spontaneous and triggered action potentials 
generated by voltage~dependent ion channels in the surface membrane. In mammalian 
heart, the cardiac muscle contraction~relaxation cycle is mainly controlled by myoplasmic 
Ca2+ concentration. As a striated muscle, the interaction between actin and myosin 
filaments of cardiac muscle at rest is blocked by the presence of tropomyosin bound to the 
actin filament. Tropomyosin forms part of the troponin complex, from which one 
component, troponin C, has binding sites for three or four calcium ions. \Vhen a sufficient 
amount of Ca2+ becomes available for binding, tropomyosin shifts its position, allowing the 
binding of the myosin cross~bridge to the actin filament, thus initiating the contractile 
process. The overall process, which begins with action potentials in the muscle fibers and 
causes release of Ca2+ from sarcoplasmic reticulum (SR), and in the end initiates 
contraction is called excitation~contraction coupling. The effects of substances on cardiac 
contraction are associated with alteration of intracellular Ca2+ concentration and/or Ca2+ 
sensitivity of myofilaments, and are shown in figure 1.1. 
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Figure 1.1. Pathways of excitation-contraction coupling in myocardial cells. Depolarization (l) 
opens (2) both membrane voltage-gated Ca2+ channels and SR Ca21 channels controlled by 
sarcolemma located T tubule dihydropyridine (DHP) sensitive receptors. Entry of trigger Call 
potentiates release of (3) Call from the SR (CaH-induced Calt release). Crossbridges become 
active by the amount of Calf released into the cytoplasm to troponin C (4). Relaxation occurs as 
Call is removed from the cytoplasm (5) by the Ca21 pump of the SR and by Na+/CaH exchange 
across the cell membrane (Adapted from Moffett et aI., 1993). 
The increase in intracellular Ca2+ concentration results from Ca2+ entering though the 
voltage-sensitive calcium channels and Ca2+ released from SR. Both these actions could be 
initiated by depolarization. The latter also involves a Ca2+-induced Ca2+ release 
mechanism: a small amount of Ca2+ through the voltage-gated L-type Ca2t- channels andlor 
Na+/Ca2+ exchange across the surface membrane during the action potential would be 
insufficient by itself to activate the myofilaments, but would trigger a much larger release 
of Ca2+ from the intracellular stores in the SR. The released Ca2+ interacts with troponin C, 
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thereby initiating cardiac contraction. The amount of trigger Ca2+ exercises a strong 
influence on the final Calt levels attained in the cytoplasm during systole, so changes in 
the amount of trigger Calt are of major importance in the control of the myocardial 
contraction. Relaxation starts when myosin cross bridges are detached from actin. This 
requires removal of cytoplasmic Cal+, which is an active process energized by Ca2t pumps 
located both in the SR and cell membrane. Via the Ca" pump in the SR, most of the total 
Calf fe-enters SR. Via the Nat /Ca2t pump in the cell membrane, the remaining Calt are 
extruded in exchange for sodium ions, which are, in turn, extruded in exchange for 
potassium ions by the Na+/K+ pump. Thus, activation or inhibition Na+fK+ pump will 
speed up or slow down the Na+/Ca2+ exchange and, secondarily, reduce or raise the 
intracellular Ca2-!- concentration. 
A change in Ca2t- sensitivity of myofilaments can also influence the Ca2+ binding and, 
hence, the contractility. One of the mechanismis to change Ca2+ sensitivity of the 
contractile structure could be troponin I phosphorylation. Evidence shows that certain 
forms of cardiac insufficiency may be due to the decrease of Ca2+ sensitivity of contractile 
proteins, rather than a lack of Ca2+ available for activation (Herzig, 1989). Therefore, in 
addition to changes in amount of cytosolic free Ca2+, a change of muscle contractility could 
also be brought by alterations of Ca" sensitivity of myofilaments. 
1.2 Receptol'-mcdiated regulation of cardiac contractility 
Many hormones and neurotransmitters, including catecholamines, as well as several 
neuropepitidcs affecUregulate the cardiac contractility by interacting with receptors located 
in cytoplasmic and membrane regions of cardiomyocytes. 
It has become clear that many membrane receptors belong to a large Ufamily" of 
receptors that couple to guanine nucleotide binding regulatory proteins (O-proteins). 0-
proteins are membrane-associated heterotrimers composed of a, 13, y subunits. These 
subunits of the O-protein regulate effectors, such as adenylyl cyclase, phospholipase C and 
ion chatmels (reviewed by Kurachi, 1994). \Vhen the system is inactive, guanosine 
diphosphate (GDP) is bound to the a-subunit. Receptor-mediated activation of G-proteins 
occurs in a agonist dependent malUler and involves the exchange of complexed GDP for 
guanosine triphosphate (GTP) (Strader et aI., 1987). When occupied by agonisls. the 
receptors are coupled to specific effector molecules linked via certain G-proteins. Different 
G-proteins interact with their relevant effectors and modulate intracellular levels of various 
second messenger systems (figure 1.2). It is well know that several second messenger 
systems modulated by G-proteins, such as adenylyl cyclasel cyclic AMP, phospholipase CI 
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diacyglyceroll inositol-I,4,5-trisphophate (PLCIDGnp,), Ca" chatmels/ Ca" and K' 
charulClsl K+ current, are involved in the regulation of cardiac contractility. Via activation 
of those systems, substances may enhance or depress the cardiac contractility. 
Agonist 
RECEPTOR 
Adrenergic 
Cholinergic 
Serotonin 
VIP 
Histamine 
CGRP 
Adenosine 
Prostaglandin 
Somatostatin 
Vasopressin 
Angiotensin 
Endothelln 
> 
GTP GDP 
Ga*GTP 
> 
G PROTEIN EFFECTOR 2nd MESSENGER 
> 
G, ~ Adenylyl Cyclase ~ cAMP 
~ C02' Channels 
G,l 
~ Phospholipase C ~ DG, IP, 
G,2 
GK ~ K' Channels ~ Kt Current 
Figure 1.2. Diversity of receptors, guanine nucleotide binding regulatory proteins (G proteins), and 
effectors involved in membrane receptor systems. Once the agonist binds to the receptor (R), 
inlennediary G proteins (shown with a, 13, y, components) transduce the signal to effector (E) 
systems, which are coupled 10 second-messenger systems. G-protein function requires hydrolysis of 
guanosine 5 '-triphosphate (GTP). The activated fonn of G proteins involves the a subunit and 
GTP (shown as G/GTP). DO = I t2-diacylglycerol; IP) = inositol 1,4,5-triphosphate (adapted from 
Schwinn et al., 1991). 
The stimulatory O-protein (Os) activates the enzyme adenylyJ cyclase resulting in an 
increase in intracellular adenosine 3'5'-cyclic monophosphate (cAMP). The main effect of 
cAMP is to activate the cAMP-dependent protein kinases (PKA) which control cell 
function in many different ways by causing phosphorylation of various enzymes, carriers 
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and other proteins (Krebs and Beavo, 1979), therewith promoting a slow Ca'" inward 
current. This leads to an increased Ca2+ release from SR, either because it serves as a 
greater trigger for Ca2+ -dependent Ca2+ release or because it increases the filling of these 
stores with Ca'" that can be released during subsequent beats (reviewed by Scholz, 1989), 
thus enhancing the inotropic response (England et aI., 1984; Katz et aI., 1990). In contrast 
to G, protein, the inhibitory G-protein (G;) inhibits adenylyl cyclase activity, thus leading 
to a reduction in the amount of cAMP generated by the enzyme and a depression in 
contractility. 
Some receptors are coupled to a specific G-protein (Gp), which activates the enzyme 
phospholipase C, causing hydrolysis of phosphatidylinositol 4,5-bisphophate (PIP,) in the 
plasma membrane. The products of this reaction are 1,2-diacylglycerol (DG), which is 
retained in the plasma membrane, and D-myo-inositol-I,4,5-trisphophate (IP,). Both IP, 
and DO act as intracellular messengers with different functions that are eventually 
responsible for the increase of cytosolic free Ca2+, thereby causing a positive inotropic 
effect. IP) causes the release of Ca2+ from intracellular non-mitochondrial stores (Berridge 
and Irvine, 1989). DG stimulates the activity of a Ca" sensitive enzyme, protein kinase C 
(PKC), another kinase involved in the phosphorylation of proteins. PKC is a Ca'"- and 
phospholipid-dependent enzyme that is involved in the enhancement of Ca'" current 
(DeReimer et aI., 1985), the recruitment of new Ca'" channels (Strong et aI., 1987), the 
phosphorylation of contractile and cytoskeletal proteins (Naka et aI., 1983; Fabiato, 1986) 
and the regulation of smooth muscle contraction (Menkes et aI., 1986). 
The direct or at least membrane-delimited regulation of ion chalmel function by G-
proteins is a newly recognized mode of the remote-sensor-type regulation of ion channels 
(Hille, 1992). A number of the ion channels, such as K+ channels, Ca2t channels, Na+ 
channels, and CI' channels, have been shown to be regulated by G-proteins in a variety of 
tissues (reviewed by Brown and Birnbaumer, 1990). In cardiac tissue, Ok activates the K+ 
channel and causes outward current of K" (Kurachi, 1994), which may be responsible for a 
negative inotropic effect. 
1.3 Positive inotropic effects and agents 
A brief introduction of the receptor systems and their signaiwtransduction mechanisms 
of the known positive inotropic agents in the human heart is summarized in figure 1.3. 
There are two mechanisms which ultimately cause positive inotropism: 
1. Increase in intracellular Ca2+ concentration; 
2. Increase in the Ca2+ sensitivity of the contractile proteins. 
15 
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I. Increase in intracellular Ca2+ concentration 
The intracellular Ca2+ concentration can be increased via: i) increase in intracellular cAMP 
level; ii) stimulation of phosphoinositide hydrolysis (phosphoinositide turnover); iii) 
increase in intracellular Na + concentration. 
Human Myocardial Receptors 
ATP 
RECEPTORS 
13,113210," 13,1 1321 01 adrenergic 
H2 '" Histamine H2 
VIP=Vasoactive Intestinal peptide 
6-HT4 '" Serotonin 5-HT4 
POEj = Prostaglandin Ej 
AI = Adenosine AI 
M2 = Muscarinic M2 
SS .. Somatostatin 
A II = Angiotensin II 
ET = Endothelln 
cAMP DG+ 1P3 
~ jG I@ 
~ IPKCI ~ ~ / 
I Contraction I 
PIP 2 
Figure 1.3. Receptor systems and their signal-transduction mechanisms in the human heart. Gs = 
stimulatory guanine nucleotide binding protein; 0t = inhibitory guanine nucleotide binding protein; 
C = catalytic unit of adenylyl cyclase; PLC = phospholipase C; PIP2 = phosphatidylinositol 4,S-bis-
phosphate; DG = 1,2-diacylglycerol; IP) = inositol-I.4,S-trisphosphate (Adapted from Brodde et ai., 
1992). 
Illcrease ill iniracelllliar cAMP level:The adenylyl cyclase/cAMP system can be 
activated through interaction of substances with receptors, located on the plasma membrane 
and coupled to a Os protein, resulting in increased intracellular cAMP levels. These 
substances include catecholamines, histamine, vasoactive intestinal peptide (VIP). 5-
hydroxytlyptamine (5-HT), calcitonin gene-related peptide (CGRP), and prostaglandin E, 
(PGE,) (reviewed by Brodde et ai., 1992). 
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The receptors for catecholamines, mediators of sympathetic nervous system, are 
coupled to two different second messenger systems, Acting through 3,- and 3,-
adrenoceptor~adenylyl~cyclase pathway, catecholamines produce positive inotropic and 
chronotropic effects. This is considered the most powerful mechanism to increase heart 
rate and contractility (Brodde et aI., 1992), Noradrenaline, which controls the cardiac 
contractility in different physiological conditions, evokes positive inotropic effect 
predominately via BJPadrenoceptor stimulation (Kallmann et al., 1989; Motomura et al., 
1990), In addition, recent studies strongly suggested that in human heart, catecholamines 
also elicit positive inotropic effects through activation of the small proportion of a 1-
adrenoceptors coupled to phospholipase C (PLC) pathway (see below), 
Histamine exerts positive inotropic effects predominantly via H2 receptors in both 
human atrium and ventricle (Bristow et aI., 1982; Zerkowski et aI., 1993), Studies 
indicated that the cardiac effects show species differences in the type of the receptors 
involved (Chiba et aI., 1976; Hattori et aI., 1983, 1986; Elizalde et aI., 1986), The effects 
of histamine and the receptors involved in porcine heart are still unknown. 
For 5~HT, there has been dramatic progress in receptor pharmacology in the recent 
past (Bradley et aI., 1986; Hoyer et aI., 1994), and it is well known that 5-HT causes 
profound, numerous and complex actions in the cardiovascular system (Saxena and 
Villalon, 1990; 1991); however, no data are available abollt the direct effects of 5-HT on 
ventricular tissue. 5~HT exerts positive chronotropic as well as inotropic effects in atrial 
tissue, which is mediated by 5-HT, receptors (Kallmann et aI., 1990b, 199Ib), 
CORP is a neuropeptide released by sensory nerve endings that are also present in the 
heart. CORP may play an important role in the cardiovascular regulation. Previous studies 
showed that CGRP has positive inotropic and chronotropic effect in various mammalian 
hearts, including the human atrium (Mulderry et aI., 1985; Marshall et aI., 1986; Franco~ 
Cereceda et aI., 1987a,b; Ishikawa et aI., 1988), However, CGRP may be species-specific 
and using the CORP from one species in another may afflict its effects. VIP, a 28-amino 
acid~peptide neurotransmitter, was discovered as a potent vasodilator substance (Said and 
Mutt, 1970), It is present in nerves of the mammalian heart (Della et aI., 1983; Lundberg 
et al., 1984) and elicits a positive inotropic effect in human atrial tissue (Franco~Cereceda 
et aI., 1987b), The physiological effects of VIP are mediated by VIP-specific membrane 
receptors, that are coupled to adenylyl cyclase in human myocardial membrane (Taton et 
aI., 1982), 
Prostaglandins (PG.l produce a complex effects on cardiac tissue, depending on the 
type of prostaglandin, the dose used, and the animal species in which the experiments arc 
performed. In vivo experiments demonstrated that POE) may increase contractile force and 
induce tachycardia in humans. However, the role of endogenous prostaglandins in 
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regulating or modulating cardiac function remains uncertain (Karmazyn and Dhalla, 1983; 
Maisch et al.; 1991, Brodde et al" 1992). 
In addition to the receptor mediated mechanisms, an increase in intracellular cAMP 
level could also be brought about by forskolin, which directly stimulates the catalytic 
subunit of adenylyl cyclase. Other agents, such as pimobendan, milrinone, enoxinone and 
isobutylmethylxanthine (IBMX), increase cAMP by inhibiting cardiac phosphodiesterase 
III, an enzyme which converts cAMP into its inactive metabolite 5'-AMP. 
Stimulation of phosphoinositide hydrolysis:Through the PLCIDGIIP, pathway, 
angiotensin II and endothelin increase the force of contraction in human atrium (Utrata et 
aI., 1989; Moravec et aI., 1990; Brodde et aI., 1992; Zerkowski et aI., 1993). The effects 
of angiotensin II are mediated by angiotensin AT) receptors (Urata et aI., 1989; Zerkowski 
et aI., 1993), which may be associated with an increase in phosphatidylinositol turnover 
(Allen et aI., 1988). Effects and the subcellular mechanism of regulation of cardiac 
contractile function of angiotensin II in human heart and are still lacking. Endothelin is a 
21-amino peptide hormone secreted by vascular and endocardial endothelial cells 
(Yanagisawa et aI., 1988). Both ETA and ET. receptors exist in human myocardium (Bax 
et aI., 1993), and it is unknown which of the two receptors mediate the positive inotropic 
effect. 
The positive inotropic effect of the a)-adrenoceptor agonists is accompanied by an 
increase in IP, and DG (Sclunitz et aI., 1987). It is suggested that a,-adrenoceptors, 
coupled to a pertussis toxin-insensitive G-protein, activate PLC, leading to the release of 
intracellular Ca" and increased contractility (Sclmlitz et aI., 1987; Bristow et aI., 1988; 
Kohl et aI., 1989; Maisch, 1991). 
Increase in intracellular Na+ concentralion:Intracellular Na+ concentration regulates 
cardiac contractility effectively by altering intracellular Ca2+ concentration via the Na+ICa2+ 
exchange. Two such mechanisms are known: inhibition of the Na+fK+-ATPase (cardiac 
glycosides), and prolongation of the open state of No channels (DPI-201, ceveratrum 
alkaloids). Both mechanisms increase intracellular Na\ which is then exchanged for Ca2f • 
2. Increase in the Ca2+ sensitivity of the contractile proteins 
An increase in Ca2f sensitivity of the contractile proteins also enhances myocardial 
contractile force, since more Ca2+ could be bound to the contractile proteins. Some 
cardiotonic drugs, such as APP 201-533 (3-alllino-6-methyl-5-phenyl-2(IH)-pyridinone) 
cause myofibrillar Ca2+ activation instead of enhancement of Ca2+ influx. These drugs may 
therefore provide a better therapeutic concept in the treatment of cardiac insufficiency 
associated with a reduced Ca2+ sensitivity. However, an enhanced contractility may occur 
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at the expense of impaired relaxation because of the easier Ca2+ binding. A selective 
positive inotropic l1Ca2+ sensitizer ll without other associated effects is still lacking. 
1.4 Negative inotropic effects and agents 
Biogenic substances that evoke negative inotropic effects have their receptors (also 
shown in figure 1.3) coupled to two kinds of G-proteins: one inhibits adenylyl cyclase, 
which has been designated Gi and the other activates K+ channels, and has been named Ok' 
In recent years, at least three receptor systems in the human heart were suggested to 
cause negative inotropic effects by a negative coupling to adenylyl cyclase: adenosine A, 
receptor, muscarinic M2 cholinoceptor, and somatostatin receptor systems (Brodde et al., 
1992). 
Adenosine, a potent coronary vasodilator, is released from the human heart during the 
influence of catecholamines or ischemia/hypoxia and can produce negative inotropic effects 
in human atrial (both at baseline as well as after isoprenaline-stimulation) and ventricular 
(only afler isoprenaline-stimulation) myocardium (Bohm et aI., 1985, 1989, 1994). The 
effects of adenosine are mediated by adenosine AI receptors that are coupled to open 
potassium channels or to inhibit adenylyl cyclase (Bohm et aI., 1989). Gupta et al. (1993) 
reported that adenosine agonists attenuated isoprenaline-stimulated effect in human 
ventricular myocytes via a cAMP-independent mechanism, mediated by adenosine AI 
receptors. 
Similarly, acetylcholine, the main transmitter of the parasympathetic nervous system, 
induces negative inotropic responses in human myocardium (Brodde et aL, 1992; Boiun et 
aI., 1994). The effects of acetylcholine are mediated by muscarinic M, receptors which are 
coupled to both potassium channels and adenylyl cyclase in human heat1 (Brodde et aI., 
1992; Bolun et aI., 1994). Animal studies show that acetylcholine may be associated with 
either inhibition of adenylyl cyclase (Korth and KUhlkamp, 1987; Eglen et aI., 1988; 
Brodde et a!., 1992) or stimulation of inositol-IA,5-trisphosphate hydrolysis (Poggioli et 
aI., 1986; TSlUi et aI., 1987; Eglen et aI., 1988), to elicit mixed inotropic effects mediated 
by the same M, receptors (Brodde et aI., 1992). 
Somatostatin, the growth hormone release-inhibiting factol', may function as a 
neurotransmitter in the heart and was reported to be used for the treatment of acromegaly 
patients (Tokgozoglu et a!., 1993). It exerts negative inotropic effects in the atria of some 
species, including man, which are mediated via somatostatin receptors (Quirion et at, 
1979; Campbell et aI., 1982; Diez et a!., 1985; Franco-Cerecede et aI., 1987; Brodde et a!., 
1992). Somatostatin has been described to reduce the intracellular Ca2+ concentration (HOll 
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et ai., 1987) in human atrial fibres and to inhibit the noradrenaline-induced stimulation of 
atrial contractility (Franco-Cereceda et ai., 1987b), as well as to inhibit adenylyl cyclase 
activity in human ventricular myocardium (Hershberger et ai., 1988). For these above 
three substances, further investigations are required to elucidate the effects and their 
mechanisms of actions in human isolated myocardium. 
Vasopressin, a neurohypophyseal hormone, plays an important role in the regulation 
of cardiovascular function (Endoh et ai., 1992). As a vasoconstrictor and antidiuretic 
agent, it is involved in orthostasis (Davies et ai., 1976; Zerbe et ai., 1983), cardiac syncope 
(Davies et ai., 1976; Baylis and Heath, 1977), and haemorrhagic and other shock states 
(Hershey et ai., 1964, 1965, 1968). The inotropic action of vasopressin shows a wide 
range of variation among mammalian species: positive inotropy in the rat (Walker et aI., 
1988) and cat (Schoemaker et ai., 1990), but negative inotropy in the rabbit, dog (Montani 
et ai., 1980; Endon et ai., 1992) and ferret (Endon et ai., 1992). 
From the previous studies, it is interesting to notice that there are differences between 
responses in atrial and ventricular tissues. Several biogenic substances have been reported 
to cause negative inotropic effects in isolated atrial tissues, whereas few data are available 
about the direct negative inotropic effect of biogenic substances on basal contractility in 
ventricular tissues. Usually, ventricular contractility is regarded the most important 
parameter for cardiac function, but atrial tissue may contribute to a greater extent than 
considered. 
I.S Atrial function vs ventricular function 
Existing evidence showed that the anatomical, biochemical, electrical and mechanical 
properties of atrial muscle are considerably different from those of ventricular muscle 
(Goldman et ai., 1984). Atrial myocytes are smaller, branch less often, have fewer, if any, 
transverse tubules and contain specific granules that are not found in ventricular myocytes 
(McNutt and Fawett, 1969; Urthaler et ai., 1975). The velocity of contraction is higher in 
the atrium than ventricle both in spontaneously beating heart (Korecky et ai., 1974) as well 
as in isolated muscle preparations (Buccino et ai., 1967; Korecky et al., 1974). Atrial 
muscle has been found to contain a unique myosin isozyme with a higher ATPase activity 
which is associated with the greater velocity of atrial contraction (Korecky et ai., 1974; 
Long et ai., 1977; Flink et ai., 1978; Sartore et ai., 1978). The results from Urthaler et ai. 
(1975) indicate that the contractile performance of right atrial muscle is in many respects 
superior to that of right ventricular muscle. The atrial function is more affected by vagally 
mediated reflexes than ventricular function (Williams et ai., 1965; Goldman et ai., 1983). 
20 
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In several mammalian species (human, dog, cat, and frog), the Ca2+ -induced release of Ca2t 
is more developed in the atrium than in the ventricle (Fabiato et a!., 1977, 1978, 1979, 
1982). There are also significant differences between the pharmacological responses of 
atrial and ventricular muscles (Behm et a!., 1989; Kemmer et a!. 1989; Schwinger et a!., 
1991; Jalmel et a!., 1992; Holubarsch et a!., 1993). These unique characteristics of atrial 
myocardium may have relevant physiological consequences, that should not be ignored. 
The atrium functions principally as a blood reservoir and an entryway to the ventricle, 
but it also pumps weakly to help moving the blood into the ventricle. The ventricle in turn 
supplies the main force that propels the blood through either the pulmonary or the 
peripheral circulation. Because of the importance (as a power pump) in pumping blood to 
the peripheral circulation, abundant information about the mechanical characteristics of the 
left ventricle is available (Fry et a!., 1964; Glick et a!., 1965; Taylor et a!., 1967). The left 
ventricle therefore has become a target for pharmacological therapy to increase cardiac 
function. 
Atrial contraction usually causes an additional 20 to 30% of blood flow filling the 
ventricle. However, under normal resting conditions, the heart can continue to operate 
quite satisfactory without this extra 30% atrial contribution, It is capable of pumping 300 
to 400% more blood, if the body needs that (Guyton, 1986). Accordingly, few 
investigations have devoted specific attention to the atrium, 
However, atrial function may be underestimated, Evidence suggests that atrium may 
play a special and important physiological role in cardiac function, The importance of 
right atrium for heart function is obvious: the electrical impulse controlling contraction 
originates in sinoatrial node located in right atrium, In intact heart, the left atrium serves 
as a conduit for the passage of blood from the pulmonary vein to the left ventricle, as a 
reservoir for storing blood during left ventricular systole, and as a contractile chamber for 
augmentation of left ventricular filling (Matsuda et a!., 1983). Specially in pathological 
conditions, left atrial contraction makes a significant contribution to left ventricular 
function, Atrial contraction made a larger contribution to left ventricular end~diastolic 
pressure (39 vs 20%), and stroke volume (35 Vs 22%) in patients with myocardial 
infarction than in those without myocardial infarction, respectively (Rahimtoola et aL, 
1975), The ratio of active atrial emptying to left ventricular stroke volume in patients with 
myocardial infarction was significantly larger (42±12%) than in normal subjects (29±10%) 
(Matsuda et aI., 1983), Thus, although under normal conditions, atrial contraction may not 
be crucial for cardiac function, under pathological conditions, such as myocardial 
infarction, the atrial contraction has become a substantial contribution to the impaired 
cardiac function, 
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Atrial tissue can be clearly distinguished from ventricular tissue, which may have 
consequences for pharmacological response. Although, it has been reported that atrial and 
ventricular tissues respond differently to pharmacological stimulation, the undergoing 
mechanisms, and the consequences of these differences are not elucidated. Moreover, in 
contractility studies, atrial tissue is commonly used as representative of tlcardiac tissue ll • A 
study of the contractile regulation of atrial and ventricular myocardium in parallel is 
needed for better understanding the physiology of atrial and ventricular function. 
1.6 Aim of the present thesis 
The agonists and antagonists of biogenic substances, in particular, acetylcholine, 
catecholamines and histamine have been used in therapy for many years. Nowadays, more 
substances such as adenosine, angiotensin II, CORP and somatostatin are under 
investigation as they may also play a role in the physiology and pathophysiology of the 
cardiovascular system, and thus providing novel therapeutical perspectives. With regard to 
the development of new inotropic agents, it is important to investigate the effects of 
potential drugs on human cardiac tissue. 
In vivo, the changes in force of contraction in the heart can be markedly influenced 
by reflex mechanisms, and interactions with multiple factors, such as heart rate, preload, 
afterload, and neurohumoral factors. Therefore, isolated, electrically driven cardiac 
preparations provide a useful tool to examine the direct effects of substances on cardiac 
contractility under controlled conditions. To distinguish atrial and ventricular responses, 
these tissues should be studied separately, which requires in vitro methods. 
This leads to the two major purposes of this thesis: 
I. To investigate the effects and the possible mechanisms of several biogenic substances 
(5-HT, histamine, human a-CORP, angiotensin II, adenosine, somatostatin and 
acetylcholine) on contractility in human isolated myocardium. 
2. To explore the differences in the pharmacology of human isolated atrial and 
ventricular trabeculae. Special attention will be paid to responses of right atrial and 
left ventricular trabeculae from the same heart. 
In addition, some studies will be performed on porcine cardiac tissue in parallel, to 
evaluate this as a model for human cardiac tissue. If the results from porcine heart are 
comparable with human's, it may serve as a relevant and convenient model for human 
myocardium. From the results, we anticipate to compare the responses in different tissues 
and different species. To our knowledge, this is the first study on contractile responses of 
the atrial and ventricular tissues from the same heart in parallel. 
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2.1 Summary 
5-Hydroxytryptamine increases contractile 
force in porcine right atrium but not in left 
ventricle 
Positive chronotropic as well as inotropic effects of 5-hydroxytryplamine (5-HT) have been 
observed in pig atrial tissue, hut no data are available about the direct effects of 5-HT on ventricular 
tissue. In the present study we investigated inotropic effects of 5-HT on atrial and ventricular 
trabeculae obtained from hearts of 3 months old pigs, The baseline isometric contractile force was 
significantly higher in ventricular (422±128 mg) than in atrial tissue (48±ll mg). A noradrenaline 
concentration-response curve (10.8 to 10.5 M) was used to check contractile responsiveness of the tissue 
and all responses were expressed as percentage of the response to tOMS M noradrenaline. Noradrenaline 
caused a concentration· dependent increase in contractile force in both atrial and ventricular trabeculae. 
In contrast, though 5-HT (10.8 to 10-1 M) did increase force of contraction in atrial tissue (maximum: 
72±20 % of the response to noradrenaline 10.5 M), the contractility of ventriclilar trabeculae was not 
significantly affected (maximum: t2±6 %). The present data show that, in contrast to atrial tissue, 
contractile force of ventricular tissue cOlild not be significantly affected by 5-HT. To our knowledge, 
this is the first study to show that an agent which increased force of contraction in the atrium, did not 
have a corresponding effect on the ventricle. These findings may have important implications for a 
better understanding of the physiology and pharmacology of cardiac contractility. 
2.2 Introduction 
In 1985, Duncker et a!. reported that 5-hydroxytryptamine (5-HT) elicited tachycardia 
in the anaesthetized pig, and that this response could not he attributed to stimulation of the 
then known 5-HT receptors. After extensive study, it was concluded that the 5-HT-induced 
tachycardia was mediated by a new 5-HT receptor type that was clearly different from 5-HT" 
5-HT, or 5-HT, receptors (Bom et a!., 1988). In parallel, a novel 5-HT receptor site, 
positively coupled to adenylyl cyclase and designated as 5·HT" was located in cultured 
neurones from mouse embryo colliculi (Dumuis et a!., 1988, 1989). Indeed, the receptor 
involved in the tachycardic response to 5·HT in the anaesthetized pig could be characterized 
as a putative 5-HT, receptor, similar to the one found in the mouse embryo colliculi (Villal6n 
et a!., 1990, 1991). 
The tachycardic response to 5-HT was suggested to result from a direct action on the 
cardiac pacemaker cells. In vitro studies in piglet isolated right atria confirmed a direct effect 
of 5-HT on sinus rhythm, mediated by 5-HT, receptors (Kaumann 1990a). In addition to the 
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chronotropic effect, a direct inotropic effect of 5-HT, also mediated by 5-HT, receptors, was 
observed in porcine isolated atrial tissue (Kaumann et aI., 1991 a). 
The above mentioned studies clearly establish direct 5-HT, receptor-mediated 
chronotropic and inotropic effects on the atrial tissue. However, direct effects of 5-HT on the 
ventricle have not been described. Using the maximum rate of rise of left ventricular pressure 
(dP/dtm.J as an index for ventricular contractility, a recent in vivo study in pigs showed a 
significant inotropic response to 5-HT. However, when heart rate was kept constant by atrial 
pacing, the response was substantially attenuated, making it equivocal whether 5-HT had a 
direct effect on the left ventricle (Saxena et aI., 1992). Therefore, the aim of the present study 
was to investigate whether a direct inotropic effect of 5-HT can be demonstrated in porcine 
isolated left ventricular tissue. For comparison, inotropic effects of 5-HT were studied in 
isolated right atrial tissue. 
2.3 Material and methods 
2.3.1 General 
Right atrial and left ventricular tissues were obtained from 3 months old pigs, used as 
saline-controls in in vivo experiments (under pentobarbital aneasthesia, 20 mg/kg.h). The 
tissues were placed in ice-chilled oxygenated Kreb's buffer (composition in mM: NaCI 118, 
KCI 4.7, CaCI, 2.5, MgSO, 1.2, NaHCO, 25, KH,PO, 1.2 and glucose 8.3), and trabeculae 
(1 mm thickness) were carefully dissected free. The trabeculae were mounted in organ baths 
(37'C, gassed with 95% 0, and 5% CO,), and attached to Harvard isometric transducers. 
Resting tension was set to approximately 750 mg for atrial and 1950 mg for ventricular tissue, 
to provide optimal loading conditions. Tissue was paced at 1.5 Hz, using field stimulation (3 
ms, voltage 20% above threshold). 
2.3.2 Experimental protocol 
After a stabilization period of at least 60 min, baseline contractile force was recorded 
and a concentration-response curve for noradrenaline was obtained to check the viability of 
the tissue. Since the tissue was found to be irreversibly damaged after adding 
10.4 M noradrenaline, the maximal concentration of noradrenaline was limited to 10.5 M, and 
all responses were expressed as percentage of the response to this concentration. Tissues with 
less than 25 mg response to 10.5 M noradrenaline were excluded from further analysis. After 
washing and restabilization a concentration-response curve for 5-HT (10.8 to 10.4 M) was 
obtained. Following another washing and stabilization period, the concentration-response 
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curve for noradrenaline was repeated. For two ventricular trabeculae the above protocol was 
performed during inhibition of neuronal uptake by cocaine (3x I 0" M) to check the influence 
of this process on the effects of 5-HT. 
To evaluate the involvement of 5-HT, receptors in the atrial response to 5-HT, following 
the control noradrenaline concentratiollwresponse curve, 4 atrial preparations were incubated 
for 30 min with tropisetron (3xI0" M), which blocks the 5-HT, receptors (Sanders and 
Kaumann, 1992). A concentration-response curve for 5-HT was then obtained, followed by 
another noradrenaline concentration-response curve, 
2.3.3 Data presentation and analysis 
Data are presented as mean ± S.E.M. Baseline values for atrial and ventricular tissue 
were compared using an unpaired Student's Hest. Effects of noradrenaline and 5-HT were 
analyzed using an ANOV A for repeated measurements. Differences were regarded statistically 
significant, if p<0,05, 
2.3.4 Drugs 
The following drugs were used in the present investigation: norepinephrine bitartrate and 
5-hydroxytryptamine creatinine sulphate complex (Sigma, st. Louis, MO, U,S,A.), cocaine 
hydrochloride (O,P,G, Utrecht, The Netherlands) and tropisetron (ICS 205-390-ch, gift from 
Sandoz, Basle, Switzerland), Drugs were dissolved in distilled water (5-HT in 25 mM HCI) 
and fresh solutions were prepared each day. 
2,4 Results 
An example of the recording obtained from atrial and ventricular trabeculae is shown 
in figure 2.1. In both tissues noradrenaline increased the force of contraction in a 
concentration-dependent malUlcr, 5-HT clearly affected the atrial contractile force, but, in 
contrast, was virtually inactive in the ventricular preparation. 
Mean results from all experiments showed that baseline contractile force was 
significantly lower in atrial (48±11 mg, n~8) than in ventricular tissue (422±128 mg, 11~13). 
As presented in figure 2.2, the first noradrenaline concentration-response curve again shows 
an increase in contractile force in both atrial and ventricular tissue. The noradrenaline-induced 
increase in contractile force was not maximal at 10-5 M, therefore EC,o values could not be 
calculated. The submaxhnal response to this noradrenaline concentration was significantly 
higher in ventricular than in atrial trabeculae; 293±71 mg compared to 94±20 mg, 
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Figure 2, I, Recordings of the force of contraction in atrial and ventricular trabeculae, and the effects 
of increasing concentrations of 5·HT and noradrenaline, before and after 5·HT. 
The concentration-response curves for 5-HT show a clear increase in atrial contractile 
force (maximum: 72±20 % of the response to 10" M noradrenaline) (figure 2.2A), whereas 
no significant effect could be demonstrated on ventricular contractile force (maximum: 12±6 % 
of the response to 10" M noradrenaline) (figure 2.2B). The atrial contractile force increased 
more than 100 % (from 48±11 mg at baseline to 104±13 mg at 10.4 M 5-HT), whereas the 
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ventricular tissue responded with only 7 % increase (from 407±112 mg at baseline to 
439±118 mg at 10-4 M 5-HT). The absence of a significant ventricular response was also 
observed in the presence of cocaine (data not shown). 
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Figure 2.2. Concentration-effect curves for noradrenaline (NA) and S-HT in pig atrial (11=8, panel A) 
and ventricular trabeculae (11=13, panel B), and in atrial trabeculae incubated with tropisetron 
(3x I 0-6 M) after the first noradrenaline curve (11=4, panel C). Responses to S-HT are expressed as 
percentage of response to 10'$ M noradrenaline (First NA). The noradrenaline curve after S-HT 
(Second NA) is presented to indicate that the lack of response to S-HT in ventricular preparations was 
not due to deterioration of the tissue, and that tropisetron selectively blocked the 5M HT response. 
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During the course of the experiment no time related deterioration of the tissue occurred, 
since the response to noradrenaline remained unchanged (figure 2.2A+B); for atrial tissue, the 
response to 10" M noradrenaline after 5-HT was 103±15 % of the response to this 
concentration before 5-HT, while for ventricular tissue this was IOS±8 %. 
Tropisetron effectively blocked the inotropic effects of 5-HT in the atrial trabeculae 
(figure 2.2C); in the presence of tropisetron, 5-HT did bot increase contractile force at 
concentrations from 10-' 10-', while 10~ M 5-HT caused a minor effect of 12±7 % (n~4) of 
the response to noradrenaline 10's M. The response to noradrenaline was not attenuated by 
tropisetron (figure 2.2C); response to 10's M noradrenaline in the presence oftropisetron was 
128±24 % of the response to this concentration during the control noradrenaline curve. 
2.5 Discussion 
In the present study, we compared the inotropic effects of 5-HT in pig right atrial 
trabeculae to those in left ventricular trabeculae. The baseline contractile force was 
significantly higher in ventricular than in atrial trabeculae. Since the amount of tissue for 
atrial (Uld ventricular preparations was comparable, this difference may represent the different 
in-vivo functions of the two structures from which the trabeculae were obtained. Before 
administering 5-HT, we checked the viability of the tissues with noradrenaline, which induces 
inotropic effects using the same second messenger system, adenylyl-cyciase/cAMP (Brodde, 
1991), as suggested for the 5-HT, receptor-mediated inotropic effects in atrial tissue (Kaumann 
et aI., 1990a), Noradrenaline increased force of contraction in atrial as well as ventricular 
trabeculae in a concentration-related way, indicating that the mechanism of increasing force 
of contraction through the adenylyl cyclase/ cAMP pathway was intact. 
5-HT caused concentration-dependent increases in contractile force to 72% of the 
response to 10'5 M noradrenaline in pig right atrial trabeculae, and 5-HT-induced responses 
could be effectively blocked by 3xI0" M tropisetron. This is in accordance with earlier 
findings, where the positive inotropic (left atria) and chronotropic (spontaneously beating right 
atria) effects of 5-HT have been shown to be mediated by 5-HT, receptors, coupled to the 
adenylyl cyclase/ cAMP second messenger system (Kaumann, 1990a; Kaurnann et aI., 199Ia). 
However, in contrast to the atrial tissue, we now report that 5R HT failed to significantly 
increase force of contraction in ventricular tissue, substantiating the poor in vivo inotropic 
effects of 5-HT during atrial pacing in anaesthetized pigs (Saxena et aI., 1992). This absence 
of ventricular response could not be explained by a time related deterioration of the ventricular 
tissue. The unchanged noradrenaline responses (after 5-HT) would imply that the mechanism 
of increasing contractile force via the adenylyl-cyciase/cAMP pathway was still intact. 
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To our knowledge, our data demonstrate for the first time that in the mammalian heart 
an agent can elicit a positive inotropic response in the atria without having a corresponding 
effect on the ventricles. Although a functional explanation for the atrium/ventricle difference 
is not yet known, this phenomenon may contribute to a better insight in the physiology of 
atrial and ventricular contractility. Furthermore, positive inotropic effects of 5-HT, mediated 
by 5-HT, receptors, have been reported in human right (Kaumaml et ai., 1991b) and left atrial 
(Sanders and Kaumann, 1992) tissue. In view of the similarities between human and pig atrial 
tissue with regard to the effects of 5-HT, it would be important to establish the response to 
5-HT in human ventricular tissue, with special emphasis on the development of 5-HT4 agonists 
as positive inotropic agents. 
In conclusion, the results of this study demonstrate that force of contraction can be 
studied in isolated right atrial and left ventricular trabeculae of the pig. Whereas in atrial 
trabeculae force of contraction can be significantly increased by noradrenaline and 5-HT, the 
ventricular trabeculae respond to noradrenaline, but not significantly to 5-HT. A similar lack 
of effect of 5-HT on human ventricle could have important consequences from the point of 
view of drug development. 
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Chapter 3 5-Hydl'oxytryptamine stimulates human 
isolated atrium but not ventricle 
3.1 Summary 
Although S-hydroxytryptamine (5-HT) elicits positive inotropic effects on the human isolated 
atrium via 5-HT4 receptors, no data are available about the effects on the ventricular myocardium. 
We investigated the inotropic effects of 5-HT in human healthy ventricular trabeculae and compared 
it to the effects in right atrial trabeculae. Baseline contractile force as well as the response to 
noradrenaline, used to check inotropic responsiveness of the tissue, were significantly higher in 
ventricular (391±IO and 719±126 mg, respectively) than in atrial tissue (I89±5 and 383±79 mg, 
respectively). However, 5-HT increased force of contraction in atrial trabeculae up to 309±82 rug at 
10-4 M, but completely failed to affect contractile force of ventricular tissue, We conclude that, in 
contrast to atrial tissue, 5-HT is ineffective as positive inotropic agent in human ventricular trabeculae. 
This finding obviously niles out development of 5-HT4 receptor agonists for the treatment of heart 
failure, but suggests the absence of ventricular side effects with the potential use of 5-HT4 receptor 
(ant)agonists in gastrointestinal disorders, 
3.2 Introduction 
5·Hydroxyhyptamine (5-HT) affects the mammalian heart by a variety of receptors. The 
receptors involved vary with species; for example, 5-HT-induced tachycardia is mediated by 
5-HTJ (cat), 5-HT, (rat, dog), 5-HT, (rabbit, dog) or5-HT, (Pig) receptors (Villalon et aI., 
1990; Saxena and Villalon, 1991). Recently, 5-HT, receptors, which are positively coupled 
to adenylyl cyclase (Dumuis et aI., 1989), have received more attention for being involved in 
the positive inotropic response to 5-HT. The 5-HT -induced increase in contractile force in 
porcine left atrium (Kaumann et aI., 1991a) and human right (Kaumann et aI., 1991b) as well 
as left (Sanders and Kaumann, 1992) isolated atrial tissue is mediated by 5-HT, receptors. 
Although, we recently reported a lack of inotropic responses to 5-HT in porcine left 
ventricular tissue (Schoemaker et aI., 1992), direct effects of 5-HT on human ventricular tissue 
are not known, Despite the potential disadvantage of ensuing tachycardia, a contractile effect 
of 5-HT on the ventricular tissue may open opportunities to develop new positive inotropic 
agents. Therefore, in the present study we investigated the effects of 5-HT on human healthy 
left ventricular tissue, For comparison, inotropic responses to 5-HT were also studied in the 
right atrial tissue. 
31 
5-HT ill humall myocardium 
3.3 Material and methods 
Hearts. obtained via Eurotransplant (LeidenJRotterdam) from donor subjects dying from 
non-cardiac causes, were kept in cold cardioplegic solution for 4-20 h. Right atrial and left 
ventricular trabeculae of approximately I mm thickness were careftilly dissected and mounted 
in the organ baths containing Krebs' solution (composition in mM: NaC1118, KCI4.7, CaCl, 
2.5, MgSO, 1.2, NaHCO, 25, KH,PO, 1.2 and glucose 8.3), gassed with 95% 0, and 5% CO, 
at 37 'C. Resting tension was set to 750 mg for atrial tissue and 1950 mg for ventricular 
tissue, to provide optimal loading conditions. The tissue was paced at 1 Hz and tension 
development was recorded using a Harvard isometric force transducer. After stabilization for 
at least 60 min, a cumulative concentration-response curVe for noradrenaline was obtained to 
check tissue viability. Since trabeculae were irreversibly damaged at 10-4 M noradrenaline, 
the maximal concentration of noradrenaline was restricted to 10's M, and all effects were 
expressed as percentage of this response. Subsequently, after washing and restabilization for 
at least 30 min, a cumulative concentration-response curve for 5-HT (10.8 to IO-~ M) and, after 
again washing and stabilization, another one for noradrenaline were obtained, For two 
ventricular preparations the above protocol was performed during inhibition of neuronal 
uptake by cocaine (3xI0" M) to check the influence of this process on the effects of 5-HT. 
To evaluate the involvement of 5-HT, receptors in the atrial response to 5-HT, following the 
control noradrenaline concentration-response curve, 6 atrial preparations were incubated for 
30 min with 3x I 0.6 M tropisetron, used as an antagonist of 5-HT~ receptors (Sanders and 
Kaumann, 1992). A concentration-response curve for 5-HT was then obtained, followed by 
another noradrenaline concentration-response curve. 
Data are presented as means±S.E, Baseline values of atrial and ventricular tissue were 
compared using an unpaired Student' I-test. Effects of noradrenaline and 5~HT were analyzed 
llsing an ANOY A for repeated measurements. Differences were regarded statistically 
significant, jf p < 0.05. The study was approved by our ethics committee. 
The drugs used in the present investigation were: norepinephrine bitartrate and 
5-hydroxytryptamine creatinine sulphate complex (Sigma, St. Louis, MO, U.S.A.), cocaine 
hydrochloride (O.P.G. Utrecht, The Netherlands) and tropisetron (ICS 205-390-ch, gift from 
Sandoz, Basle, Switzerland). Drugs were dissolved in distilled water (S-HT in 25 mN HC!) 
and fresh solutions were prepared each day, 
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3.4 Results 
An example of the recording obtained from atrial and ventricular trabeculae is shown 
in figure 3.1. In both tissues noradrenaline increased the force of contraction in a 
concentrationadependent manner. SaHT clearly affected the atrial contractile force, but, in 
contrast, was virtually inactive in the ventricular preparation. 
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Figure 3.1. Recordings of the force of contraction in atrial and ventricular trabeculae, and the effects 
of increasing concentrations of 5a HT and noradrenaline, before and after 5a HT. 
33 
5-HT in human myocardium 
RIGHT ATRIUM LEFT VENTRICLE 
-« 
z A B I 
::;; 150 150 • 
"I I j; '" • ... 0 100 ° 100 ... /' OJ 
'" .y' 
" 50 50 0 1° c. 
'" OJ 0:: 0 I""'" 0 II~I-III-III-I!I 
'if'. 
8 7 6 5 4 8 7 6 5 4 
-« C 
-Log [Agonist] 
z 
:::; 150 
"I 
'" 0 First NA ... / . 0 100 .. 
OJ ~/I/ III 5-HT '" c: 50 0 ell Second NA c. 
'" '" 1II~1lI-1il/1 0:: 0 
'if'. 
8 7 6 5 4 
-Log [Agonist] 
Figure 3.2. Concentration-effect curves for noradrenaline (NA) and 5-HT in atrial (n=12, panel A) 
and ventricular (n=IO, panel B) trabeculae, and in atrial trabeculae incubated with Iropisetron (3xIO·6 
M) after the first noradrenaline curve (n=6, panel C). Responses to 5-HT are expressed as percentage 
of response to 10.5 M noradrenaline (First NA). The noradrenaline curve after 5-HT (Second NA) is 
presented 10 indicate that the lack of response to 5-HT in ventricular preparations was not due to 
deterioration of the tissue, and that tropisetron selectively blocked the S-HT response. 
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Mean results showed that baseline contractile force was significantly higher in 
ventricular (391±76 mg; n=IO) than in atrial (189±55 mg; n=12) trabeculae. As presented in 
figure 3.2, noradrenaline caused concentratiollkdependent increases in atrial and ventricular 
contractile force, which were at the highest concentration, 10" M, 383±79 mg and 
719±126 mg for atrial and ventricular tissue, respectively. Since the responses to 10" M 
noradrenaline were not maximal, EC" values could not be calculated. 5-HT increased atrial 
force of contraction (figure 3.2, panel A) approximately 2.5 times (from 223±66 mg to 
532±96 mg at 10" M). The atrial responses to 5-HT were effectively antagonized by 
3xlO-6 M tropisetron (a rightward shift in the 5-HT concentration response curve of 
approximately 1.6 log units), while the responses to noradrenaline were not affected 
(figure 3.2, panel C). 
In contrast to the atrial tissue, no inotropic effect of 5~HT could be demonstrated in the 
ventricular tissue (figure 3.2, panel 8). The absence of ventricular response was also observed 
in the presence of cocaine (data not shown). During the COUl'se of the experiment no time 
related deterioration of the tissue occurred, since the noradrenaline concentration-response 
curve obtained after 5-HT was not depressed compared to the one obtained before 5-HT 
(figure 3.2, panels A and 8). 
3.5 Discussion 
In the present study, we compared the inotropic effects of 5-HT in human left 
ventricular trabeculae to those in right atrial trabeculae. The baseline contractile force was 
significantly higher in ventricular than in atrial trabeculae. Before administering 5-HT, we 
checked the viability of the tissues with noradrenaline, which induces inotropic effects using 
the same second messenger system, adenylyl-cyclase/cAMP (Brodde, 1991), as suggested for 
the 5-HT, receptor-mediated inotropic effects in atrial tissue (Kaumann et aI., 199Ib). 
Noradrenaline increased force of contraction in atrial as well as ventricular trabeculae in a 
concentration-related way, indicating that the mechanism of increasing force of contraction 
through the adenylyl cyclase/cAMP pathway was intact. 
5-HT caused concentration-dependent increases in contractile force to 82% of the 
response to 10" M noradrenaline in human right atrial trabeculae, and the effect of 5-HT was 
effectively blocked by 3x10-6 M tropisetron, without the modification of the response 
noradrenaline. This is in accordance with earlier findings; the atrial positive inotropic effects 
of 5-HT were sensitive to tropisetron, indicating mediation by 5-HT4 receptors, coupled to the 
adenylyl cyclase/cAMP second messenger system. Moreover, atrial 5-HT effects were 
insensitive to l3-blockade, indicating a lack of indirect effect via release of noradrenaline 
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(Kaumann et aI., 1991 b, Sanders and Kaumann, 1992). However, in contrast to the atrial 
tissue, we now report that 5~HT failed to increase force of contraction in ventricular tissue. 
The absence of a ventricular response supports the lack of 5-HT-induced release of 
noradrenaline from sympathetic neurons, and cannot be explained by a time related 
deterioration of the ventricular tissue. The unchanged noradrenaline responses after 5~HT 
imply that the mechanism of increasing contractile force via the adenylyl-cyclase/cAMP 
pathway was still intact. The results of the present study, showing tropisetron~sensitive 
inotropic responses to 5R HT in atrial but not in ventricular tissue, are similar to those we 
recently reported in hearts of 3 months old pigs (Schoemaker et aI., 1992). 
In conclusion, the most salient finding of the present study is that, in contrast to atria, 
5-HT fails to affect the ventricular tissue. To our knowledge, this report demonstrates for the 
first time that in the human heart an agent can elicit a positive inotropic response in the 
atrium without having a corresponding effect on the ventricle. Besides possible contribution 
to a better insight in the physiology of atrial and ventricular contractility, the present findings 
have important pharmacological implications. They obviously rule out the development of 
5-HT, receptor agonists for the treatment of heart faillire and, in addition, predict lack of 
ventricular side~effects during anticipated use of 5~HT4 receptor agonists and antagonists in 
gastrointestinal disorders (Clarke et aI., 1989). 
36 
Chapter 4 
4.1 Summary 
Effects of histamine on porcine isolated 
myocardium: differentiation from effects on 
human tissue 
Inotropic effects of histamine have been extensively studied in many species. However, data 
about the porcine myocardium, which is often used as a model for the human heart, are not 
available. We investigated inotropic effects of histamine on atrial and ventricular trabeculae 
obtained from porcine hearts. For comparison, we also evaluated the effects of histamine on 
human myocardium. Histamine caused concentration-dependent increases in contractile force in 
porcine and human atrial tissue (at 10') M: 267±70 mg and 317±81 mg, or 133±17% and 8S±12% 
of the response to 10'~ M noradrenaline, respectively) as well as in porcine and human ventricular 
tissue (at 10·' M: 592±148 mg and 773±203 mg, or 68±13% and 122±61% of response to 10·' M 
noradrenaline, respectively), Cimetidine, but not mepyramine. antagonized the contractile effects of 
histamine in porcine and human atrial, and in human ventricular tissues. In contrast, the hislamine~ 
induced positive inotropic effect in porcine ventricular tissue was antagonized by mepyramine, but 
not by cimctidine, Propranolol failed to block the inotropic effect of histamine in all four tissues. 
These results indicate that, similar to human atrial trabeculae, the positive inotropic effect on 
porcine alrial trabeculae is mediated by H2 receptors. In contrast to human ventricular trabeculae, 
however, the positive inotropic effect on porcine ventricular trabeculae appears to be mediated by 
HI receptors. 
4.2 Introduction 
Histamine elicits positive inotropic effects on the hearts of various animal species 
(Levi et aI., 1982). The effects of histamine apparently are mediated in the dog by HI 
receptors (Chiba et aI., 1976; Chiba, 1977), in the monkey by H, receptors (Hattori et aI., 
1883), in the guinea-pig (Black et aI., 1972; Ledda et aI., 1977; Verma et aI., 1977) and 
rabbit (Elizalde, 1986; Hattori et aI., 1988, 1991) by both HI and H, receptors, and in the 
cat and rat (Lahcr and McNeill, 1979, 1980) by endogenous catecholamine release. In the 
human heart, the effects of histamine on contractile function, both in vivo and in vitro, 
have been studied extensively. The increase in force of contraction in the atrium and 
ventricle are mainly mediated by H2 receptors, although both receptor subtypes, HI and H2, 
may exist in the heart (Ginsburg et aI., 1980a,b, 1981; Guo et aI., 1984). Thus, the cardiac 
effects of histamine show species differences in their mechanism of action and in the type 
of histamine receptors involved (Owen, 1977). 
37 
Histamine in porcine and human myocardium 
Another substance that shows clear species difference in its cardiac responses with 
respect to the receptor type involved is 5-hydroxytryptamine (5-HT) (Saxena and Villalon, 
1991). Recently, however, we demonstrated that the contractile effects of 5-HT were 
similar in human and porcine cardiac tissue. In both species, 5-HT increased contractile 
force in atrial tissue, mediated by 5-HT, receptors (Kaumann et aI., 1991a,b; Schoemaker 
et aI., 1992, 1993), but it failed to affect the force of ventricular contraction (Jahnel et aI., 
1992; Schoemaker et aI., 1992, 1993). So far, the pig appears to be the only species in 
which the effects of 5-HT on cardiac tissues mimic those in humans. If the finding for 
5-HT could be extended to other substances. such as histamine. the porcine isolated cardiac 
tissue may serve as a relevant and convenient model for the human myocardiwn. 
We investigated the effects of histamine in porcine isolated atrial and ventricular 
myocardium. as well as the receptors involved in its effects, For comparison, the responses 
to histamine in the human myocardium were also evaluated. 
4.3 Material and methods 
4.3.1 Preparations 
Right atrial and left ventricular trabeculae were obtained from hearts of 3 months old 
Yorkshire pigs used as saline-controls in other in vivo experiments (under pentobarbital 
anaesthesia, 20 mglkg.h) and from 7 heart beating organ donors (5 male, 2 female; age 11-
42 years), who died of non-cardiac disorders (I cerebrovascular accident, 5 poly trauma, I 
encephalopathy) less than 24 h before the tissue was taken to the laboratory. The hearts 
were kindly provided by the Rotterdam Heart Valve Bank (Bio Implant Services 
Foundation I Eurotransplant Foundation) after removal of the aortic and pulmonary valves 
for homograft valve implantation. These hearts were stored at 0-4 °C in a sterile organ 
protecting solution (UW, EuroCollins, or HTK-Brettschneider, see Ploeg et aI., 1992) 
immediately after circulatory arrest. After excision, tissue samples were placed in ice-
chilled oxygenated Kreb's buffer (composition in mM: NaCI 118, KCI 4.7, CaCI, 2.5, 
MgSO, 1.2, NaHCO, 25, KHPO, 1.2 and glucose 8.3) and trabeculae «I mm thickness) 
were carefully dissected free. The trabeculae were mounted in organ baths (15 ml Kreb's 
buffer, 37'C, gassed with 95% 0, and 5% CO,), and attached to Harvard transducers for 
isometric tension measurement. Resting tension was set to 750 mg for atrial, and to 1950 
mg for ventricular tissue in order to provide optimal loading conditions. Tissues were 
paced at 1.5 Hz for porcine and I Hz for human tissue, using electrical field stimulation 
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(3 ms, voltage 20% above threshold), according to the different heart rates in vivo of the 
two species. 
4.3.2 Experimental protocol 
After stabilization, resting tension and baseline contractile force were measured. A 
concentration-response curve to noradrenaline was obtained to check inotropic 
responsiveness of the tissues. Since the tissues were found irreversibly damaged after 
exposure to 10·' M (the baseline contractile force decreased after washout and did not 
recover in reasonable time), the maximum concentration of noradrenaline was restricted to 
10's M. Since no maximum was reached for the concentration-response curve for 
noradrenaline, pDl values were not calculated. Tissues with less than 25 mg response were 
excluded from further analysis. Responses to histamine were expressed as percentage of 
the response to 10.5 M noradrenaline. 
After washing (six times) and stabilization (at least 10 min), the porcine atrial and 
ventricular tissues were divided into four groups. In group 1, serving as control, a 
concentration response curve for histamine (10-6 M to 10-) M) was obtained without 
antagonists. In the three other groups, a histamine concentration-response curve was 
obtained after 30 min incubation with either 10-5 M cimetidine to block H2 receptors 
(English et aI., 1986), 10.7 M mepyramine to block HI receptors (Black et aI., 1982) or 
10"' M propranolol to investigate a possible indirect fi-adrenoceptor-mediated effect via 
endogenous noradrenaline release (Ginsburg et al 1980a). In order to avoid possible 
desensitization to histamine, only one histamine curve per preparation was obtained. After 
washing and restabilization, another noradrenaline concentration-response curve was 
obtained in each preparation to check viability of the tissue. 
Since the effects of histamine on the human cardiac tissue are known, only two groups 
of experiments were performed; control and after incubation of 10-50 M cimetidine. 
4_ 3. 3 Data pl'esenlatlon and analysis 
Data are presented as mean± S.E.M. Baseline values for atrial and ventricular tissue 
were compared using an unpaired Student's t-test. The effects of noradrenaline and 
histamine were analyzed using an ANOV A for repeated measurements. Differences were 
regarded statistically significant, if p<0.05. In the case of a complete concentration 
response curve (for control histamine the response to to-3 M was taken as the maximum 
response), curves were fitted to a four parameter logistic function (Lean et aI., 1987) which 
provided the PD, values. 
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4.3.4 Drugs used 
The compounds used in the present study were: noradrenaline bitartrate and histamine 
dihydrochloride (Sigma, St. Louis, MO, U.S.A.), cimetidine base (Smith Kline Beecham, 
Rijswijk, The Netherlands), propranolol hydrochloride (Imperial Chemical Industries 
Limited, Macclesfield, U.K.), mepyramine maleate (Rh6ne-poulenc, Paris, France). 
4.4 Results 
4.4.1 Porcine myocardium 
4.4.1.1 Effects of noradrenaline and histamine. An example of the recording 
obtained from atrial and ventricular trabeculae is shown in figure 4.1. In both tissues 
noradrenaline and histamine increased contractile force in a concentration-dependent 
manner. In all ventricular tissues, at each histamine concentration the positive inotropic 
effect was preceded by a transient negative inotropic effect. 
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Figure 4.1. Recording of the effects of cumulative concentrations of noradrenaline (10-8_10-5 M) 
and histamine (10-6_10-) M) on porcine atrial and ventricular trabeculae. Note that in ventricular 
tissue the positive inotropic effect of histamine is preceded by a transient negative inotropic effect. 
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Figure 4.2. Cumulative concentration response curves for histamine (_) in porcine atrial (n=7) and 
ventricular (n=6) tissues, as compared to the contractile effects of noradrenaline (A). 
The mean concentration-response curves are shown in figure 4.2. After stabilization, 
the baseline contractile force was 134±36 mg (n~29) and 320±56 mg (n~25) in atrial and 
ventricular tissues, respectively. At 10-5 M noradrenaline, force of contraction increased to 
290±43 mg (n~29) in atrial and to 588±91 mg (n~25) in ventricular tissues, Over the 
concentration range of 10.6 M to 10.3 M, histamine also caused concentration-dependent 
increases in force of contraction. Atrial tissue generated a relatively greater response to 
histamine (133±17% of response to 10" M noradrenaline, at 10') M, n~6) than ventricular 
tissue (68±13% of response to 10" M noradrenaline at 10') M, IF6), The pD, for 
histamine was 4.9±O.2 in atrial and 5.1±0.2 in ventricular tissue. After histamine had been 
washed out, the contractile force in atrial, but not in ventricular tissues, remained 
significantly elevated compared to that before histamine (table 4,1), This was not observed 
with noradrenaline (differences between before and afier noradrenaline: 29±34 and 
50±30 mg, in atrial and ventricular tissue, respectively), At the end of the protocol, 
noradrenaline could increase force of contraction in atl tissues up to comparable values as 
at the beginning of the protocol (at 10" M: 372±64 and 545±74 mg in atrial and 
ventricular tissue, respectively). 
4.4,1.2 Effects of antagonists. 
(mepyramine), H, (cimetidine) or fi 
Three antagonists were 
(propranolol) receptors, 
baseline contractile force in either atrial or ventricular tissues 
used to block either H, 
None of them affected 
(cimetidine: 101±18 and 
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103±16 mg (atria), 264±48 and 267±49 mg (ventricles); mepyramine: 112±48 and 
112±48 mg (atria), 124±29 and 116±27 mg (ventricles); propranolol: 293±137 and 
266±124 mg (atria), 240±72 and 260±67 mg (ventricles), before and after 30 min 
incubation, respectively). 
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Figure 4.3. Concentration response curves of histamine in porcine atrial and ventricular tissues 
without (Iil, control, n=6) or after incubation with either 10.7 M mepyramine (.6., n=6), lO-s M 
cimetidine (0, n=6) or 10-6 M propranolol (0, n=7). . 
Table 4.1. Contractile force (mg) in porcine atrial and ventricular trabeculae (n=6 each) before 
exposure to histamine and after washout of histamine. 
Preincubation Atrium Ventricle 
Before After Before After 
None (control) 124±56 236±69+ 385±101 468±106 
Mepyramine (10-7 M) 98±42 323±148+ 110±26 I 62±50 
Cimetidine (10-' M) I 34±42 246±80' 343±85 397±90 
* Significantly different from values before histamine, 
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Cimetidine (10" M) antagonized the contractile effects of histamine in the atrial but 
not in ventricular tissue. In contrast) mepyramine (l0·7 M) antagonized positive inotropic 
effects of histamine in ventricular but not in atrial tissues (figure 4.3). However, the 
concentration response curve for histamine in the presence of cimetidine and mepyramine 
suggest a biphasic course rather than a parallel shift to the right. Propranolol (10" M) did 
not block the increase in contractile force produced by histamine in either atrial or 
ventricular tissue (figure 4.3). Additionally, mepyramine but not cimetidine or propranolol 
eliminated the transient negative inotropic effects of histamine in the ventricle (data not 
shown). The increase in baseline contractile force following exposure to histamine was not 
attenuated by previous treatment with either cimetidine or mepyramine (table 4.1). 
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Figure 4.4. Recording of the effects of cumulative concentrations of noradrenaline (lO,sRIO·1 M) 
and histamine (10-6~1O.3 M) on human atrial and ventricular trabeculae. 
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4.4,2 Human myocardium 
An example of the recording obtained from atrial and ventricular trabeculae is shown 
in figure 4.4. Noradrenaline and histamine increased contractile force in a concentration 
dependent marmer in both tissues, The negative inotropic effect preceding the positive 
inotropic effect, which was seen in all porcine ventricular tissues at each histamine 
concentration, occurred in human tissue only at 10-3 M in about 75% of the preparations. 
The mean results are presented in figure 4,5, Baseline contractile force in left 
ventricular tissues was significantly higher (242±42 mg, n= 12) than in right atrial tissues 
(47±9 mg, n=13), At 10" M noradrenaline, the force of contraction went up to 298±50 mg 
(n=12) in atrial and 636±1I2 mg (n=l3) in ventricular tissues, Histamine (10"' M to 
10-3 M) caused concentration~dependent increases in force of contraction in atrial (at 
10') M: 85±12% of response to 10" M noradrenaline) and in ventricular (at 10') M: 
122±61% of response to 10" M noradrenaline) tissues (figure 4,5), The pD, for histamine 
was 4.9±0.2 in atrial and 5.0±0.1 in ventricular tissues. 
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Figure 4.5. Cumulative concentration response curves for histamine (Ill) in human atrial (n=6) and 
ventricular (n=6) tissue, compared to contractile effects of noradrenaline (A). 
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Figure 4.6. Concentration response curves of histamine in human atrial and ventricular tissues in 
the absence (II, control, 11=6) or presence of 10's M cimetidine (0, n=7), 
Table 4.2. Contractile force (rug) in human cardiac tissues (0=6 each) before exposure to histamine 
and after washout of histamine, 
Preincubation 
None (control) 
Cimetidine (10" M) 
Atrium 
Before After 
52±12 225±51* 
72±27 218±69* 
>Ie Significantly different from values before histamine. 
Ventricle 
Before After 
350±86 590±185* 
240±55 330±81* 
Cimetidine shifted the concentration-response curve for histamine to the right 
(figure 4.6); for atrial tissue with 1.1 and for ventricular tissue with 2.1 log units. 
Cimetidine did not block the transient negative inotropic effect observed at 10" M 
histamine (results not shown). After histamine had been washed Qut, both atrial and 
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ventricular tissues restabilized at a higher baseline contractile force (table 4.2), which was 
not observed with noradrenaline (differences between before and after noradrenaline: 15± 16 
and 29±52 mg, in atrial and ventricular tissue, respectively). Cimetidine did not abolish 
the increase in baseline contractile force in atrial tissue, and only partly reversed it in 
ventricular tissue (table 4.2). Noradrenaline stimulation at the end of the protocol 
increased contractile force to comparable values at 10-s M noradrenaline as at the beginning 
of the protocol (275±74 and 633±111 mg, for atrial and ventricular tissues, respectively). 
4.5 Discussion 
In the present study, we investigated the contractile response of histamine in porcine 
myocardium as a potential model for human myocardium. In the latter, histamine 
increases contractile force using the adenylyl cyclase/cAMP pathway (Bristow et aI., 1982). 
Therefore, to begin with we checked contractile responsiveness of the tissues though 
stimulation of the adenylyl cyclase/cAMP pathway using noradrenaline (Brodde, 1991). 
Baseline contractile force as well as the response to 10" M noradrenaline appeared higher 
in ventricular than in atrial trabeculae, which may be related to the different in vivo 
functions of the tissues. The data are comparable to those previously reported by our 
group (Schoemaker et aI., 1992, 1993). 
In the present study, the increase in force of contraction in human right atrial and left 
ventricular trabeculae induced by histamine as well as the ability of cimetidine to 
antagonize the responses to histamine are in agreement with previous studies (Gristwood et 
aI., 1980, 1981; Bristow et aI., 1982), in which the positive inotropic effect of histamine 
was completely mediated by Hz receptors. The transient negative inotropic effect, observed 
at 10') M histamine, was not blocked by cimetidine and therefore appeared not to be 
mediated by Hz receptors. An HI-mediated mechanism could be responsible since these 
receptors are present in the heart (Ginsburg et al 1980a; Gristwood et aI., 1980) and are 
described to cause negative inotropic effects (Guo ct aI., 1984). Interestingly, after 
histamine had been washed out thoroughly (six times), a sustained increased in contractile 
force was noticed. This increase was also found in tissues pretreated with cimetidine. 
Although we cannot exclude a tight binding of histamine to the H, receptor, the pOol' 
antagonist effects of cimetidine may suggest that activation of intracellular mechanisms 
rather than a sustained receptor occupation is responsible for this observation. However, 
adenylyl cyclase activation is probably not involved, since noradrenaline and 5·HT 
(Schoemaker et aI., 1992, 1993) did not have any sustained effect on the baseline 
contractile force. 
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Similar to human atrial tissue, porcine atrial tissue was stimulated by histamine, and 
cimetidine, but not mepyramine, antagonized the histamine~induced inotropic effects, 
suggesting the involvement of H2 receptors. However, the shape of the histamine 
concentration response curve in the presence of cimetidine did not show a completely 
parallel rightward shift, indicating a lack of a simple, one receptor-mediated, competitive 
antagonism. Comparable to human tissue, in porcine atrial tissue histamine caused a 
sustained elevation of the baseline contractile force after washing and stabilization. 
In contrast to the human ventricular tissue, cimetidine failed to block the histamine-
induced increase in the force of contraction in porcine ventricular tissue. Instead, the HI 
receptor antagonist mepyramine effectively antagonized the contractile effect of histamine. 
However, comparable to the results with cimetidine in the porcine atrium, the shape of the 
histamine concentration response curve in the presence of mepyramine suggested a biphasic 
course rather than a parallel shift to the right, indicating that the antagonism was not 
simply competitive in nature. In any case, the effect of histamine could not be attributed 
to an indirect release of noradrenaline from sympathetic nerve terminals, as has been found 
in the rat and cat (Laher and McNeill, 1979, 1980), since propranolol failed to block the 
histamine-induced increase in force of contraction in porcine ventricular tissue. Thus, the 
data indicate that the responses to histamine in porcine ventricular tissues were mainly 
mediated by H, receptors. 
The mechanism of action for the HI receptor mediated inotropic response is still not 
clear. The activation of HI receptors can lead to an increased level of cellular cyclic GMP 
(Johnson, 1982), or phosphoinositide hydrolysis (Hattori et a!., 1991), but any relationship 
with HI receptor-induced inotropic effect is yet to be elucidated. Moreover, HI receptor 
stimulation has been associated with both positive (Ginsburg et aI., 1980a) and negative 
(Guo et aI., 1984) inotropic effects. The observation that in porcine ventricular tissues, the 
positive inotropic effect of histamine (sensitive to mepyramine) was preceded at each 
concentration by a negative inotropic effect (also sensitive to mepyramine) suggests the 
involvement of H, receptors in both positive and negative inotropic effects. The shape of 
the histamine concentration-response curve in the presence of mepyramine indicates a 
complex concentratiollMeffect relation. The lack of change in baseline contractile force in 
this tissue, in contrast to the other investigated tissues, further indicates the involvement of 
different receptors and/or mechanisms in the contractile effects of histamine in the porcine 
ventricle. 
A nonMhomogeneous distribution of histamine receptors in the heart has been found in 
other species as well. For example, in the guineaMpig heart, HI receptors are present in the 
left atrium, Hz receptors in the right atrium and both HI and H2 receptors in the right 
ventricle (Verma and McNeill, 1977). The positive inotropic effect of histamine in rabbit 
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atrium is mediated predominantly by H2 receptors, whereas in papillary muscle it is mainly 
mediated by H, receptors (Hattori et aI., 1988). Our present study provides a new example 
of atrium/ventricle difference among mammalian species. These observations imply that in 
the heart, atrial and ventricular contractility can be regulated separately. 
In conclusion, the results of our study demonstrate that histamine can significantly 
increase the force of contraction in porcine right atrial and left ventricular trabeculae. 
Similar to human myocardial trabeculae, the inotropic effect of histamine on porcine right 
atrial trabeculae is mediated by H2 receptors. However, in contrast to that in humans, the 
inotropic effect of histamine on porcine left ventricular trabeculae appears to be mediated 
by H, receptors. Although pig hearts are often used as a model for human hearts, the 
results from the present study indicate that this model too has ils limitations. 
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5.1 Summary 
Human calcitonin gene-related peptide and 
porcine isolated myocardium 
Calcitonin gene~related peptide (CORP) is considered to he a neuropeptide, potentially 
involved in the regulation of cardiac contractility. Previous investigations have demonstrated that in 
most species, including guinea~pig, rat and human, CORP exerts positive inotropic effect in atrial 
but not in ventricular tissue. In the present study, we investigated the effects of human «-CORP in 
porcine atrial and ventricular trabeculae. In contrast to human cardiac tissue, human «·CORP (l0-9 
to 10-7 M) induced a concentration-dependent positive inotropic effect in porcine ventricular, but 
not in atrial trabeculae, Whether this discrepancy is due to the use of human CORP or to 
differences in the distribution of CGRP receptors in different parts of the heart remains unknown. 
These results show that a biogenic substance can induce a different response in different species, 
which may probably be mediated by the same receptor. Although porcine and human heart show 
similar responses to several biogenic substances, the present results indicate that the porcine heart 
model also has its limitation. 
5.2 Introduction 
Calcitonin gene-related peptide (CORP) is a 37-amino acid neuropeptide released by 
sensory nerve fibres. CORP is found in almost all tissues and is considered to be a 
neurotr~nsmitter or neuromodulator, also within the cardiovascular system (Oennari et aI., 
1985). Its effects on the cardiovascular system, including positive chronotropic and 
inotropic actions (Ishikawa et aI., 1988; Anand et aI., 1991), suggest that CORP may be 
involved in the regulation of cardiac contractility. Previous investigations have shown that 
in most species, such as rat (Mu1derry et aI., 1985) and guinea-pig (Ishikawa et aI., 1988), 
as well as in man (Franco-Cereceda et aI., 1987a,b; Du et aI., 1994), rat or human a-
CORP exerted positive chronotropic and inotropic effect in atrial but not in ventricular 
tissue. However, in contrast to these species, a positive inotropic effect of human CORP 
was reported in porcine ventricular false tendons (Miyauchi et aI., 1988). Meanwhile, 
CORP is species~specific and using the CORP from one species in another may afflict its 
effects. For instance, rat CORP was about 10 times more potent than human CORP in 
increasing the rate of contraction in gllinea~pig atria, and both human and rat CORP failed 
to altered the rate of contraction in rabbit isolated perfused heart (Marshall et aI., 1986). 
Porcine heart is used as a model for the human heart, as it responds similarly to 
several biogenic substances, including noradrenaline (Du et aI., 1993; Schoemaker et aI., 
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1993), histamine (Du et aI., 1993) and 5-HT (Schoemaker et aI., 1993). These substances 
act by stimulation of the same receptor subtypes in porcine and human hearts, except for 
histamine where the HI receptor instead of H2 was involved in the response of porcine 
ventricular tissue. Because of this similarity of human and porcine heart, and the fact that 
porcine CORP is not yet available, we studied the effects of human a-CORP in porcine 
atrial and ventricular tissue, and compared the results to the effects in the human 
myocardium (Du et aI., 1994). 
5.3 Material and methods 
5.3.1 Preparations 
Right atrial and left ventricular tissues were obtained from 3 months old pigs, used as 
saline-controls in in vivo experiments (under pentobarbital aneasthesia, 12 to 20 mg/kg.h). 
The tissues were placed in ice-chilled oxygenated Kreb's buffer (composition in mM: NaCI 
118, KCI 4.7, CaCl, 2.5, MgS04 1.2, NaHCO, 25, KH,P04 1.2 and glucose 8.3), and 
trabeculae «I mm thickness) were carefully dissected free. The trabeculae were mounted 
in organ baths (37'C, gassed with 95% 0, and 5% CO,), and attached to Harvard isometric 
transducers. Resting tension was set to approximately 750 mg for atrial and 1950 mg for 
ventricular tissue, to provide optimal loading conditions. Tissue was paced at 1.5 Hz, 
using field stimulation (3 ms, voltage 20% above threshold). 
5.3.2 Experimental protocol 
Similar to our previous studies (Schoemaker et aI., 1993; Du et aI., 1993), after a 
stabilization period of at least 40 min, baseline contractile force was recorded and a 
concentration-response curve for noradrenaline was obtained to check the viability of the 
tissue. The maximal concentration of noradrenaline was limited to lOS M, and all 
responses were expressed as percentage of the response to this concentration. Tissues with 
less than 25 mg response to 10.5 M noradrenaline were excluded from further analysis. 
After washing and restabilization a concentration-response curve for CORP (10-9 to 
10-7 M) was obtained in both atrial and ventricular tissue. Following another washing and 
stabilization period, the concentration-response curve for noradrenaline was repeated to 
testify if the tissue was still viable. 
5_3.3 Data preselltatioll and analysis 
Data are presented as mean ± S.E.M. Baseline values for atrial and ventricular tissue 
were compared using an unpaired Student's t-test. Effects of noradrenaline and CORP 
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were analyzed using an ANOV A for repeated measurements, Differences were regarded 
statistically significant, if p<O,05, 
5,3.4 Compounds used 
The compounds used in the present investigation were: norepinephrine bitartrate 
(Sigma, st. Louis, MO, U,S,A.) and human CORP (Saxon, Hannover, F,R,O,), 
5.4 Results 
An example of the recording obtained from atrial and ventricular trabeculae is shown 
in figure 5.1. In both tissues noradrenaline increased the force of contraction in a 
concentration~dependent manner. CORP clearly increased the ventricular contractile force, 
but, in contrast, was virtually inactive in the atrial preparation. 
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Figure 5.1. Recording of force of contraction in atrial and ventricular trabeculae showing the 
effects of noradrenaline (before and after CORP) and human CORP in increasing concentrations. 
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Figure 5.2. Cumulative concentration-response curves of noradrenaline (NA, before and after 
CORP, upper panels) and CORP (lower panels), obtained in atrial (n=6) and ventricular (11=10) 
trabeculae, respectively. 
Mean results (figure 5,2) from all experiments showed that baseline contractile force 
was significantly lower in atrial (SO±16 mg, n~6) than in ventricular tissue (S9S±138 mg, 
n= 1 0). Noradrenaline (before 9GRP concentration-response curve) increase in force of 
contraction up to 213±S9 mg in atrial (n~6) and IISI ±S40 (n~ 1 0) mg in ventricular 
trabeculae at the concentration of 10·' M. CORP (10·' to 10.7 M) did not change the atrial 
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contractility (baseline: 107±26 mg, 10.1 M CGRP: 103±25 mg, n=6). However, in 
ventricular trabeculae, CORP induced a concentration~dependent increase in force of 
contraction from 545±110 mg at baseline up to 663±119 mg, or 2l±3 % of the response to 
10·' M noradrenaline (n=10, P<0.05). After the CGRP concentration-response curve, 
noradrenaline again showed a cOllcentration~dependent increase in contractile force in both 
atrial and ventricular trabeculae (at 10·' M: 84±7%, n=6 and 100±6%, n=10 of the response 
to this concentration before CORP, in atrial and ventricular trabeculae, respectively). 
5.5 Discussion 
In the present study, we observed that atrial baseline contractile force was much 
lower than that in ventricular preparations and that responses to noradrenaline in both atrial 
and ventricular preparations were similar before and after CORP. These results confirm 
our previous observations (Schoemaker et ai., 1993; Du et aI., 1993) and rule out a major 
influence of variation or deterioration of the tissue in the present experiments. 
\Ve demonstrated that human CGRP induced a positive inotropic effect in porcine 
ventricular tissue but not in atrial tissue. This is in contrast with our previous findings 
using human CORP in human cardiac tissues; human CORP increased human atrial but not 
ventricular contractility (Du et aI., 1994). The present results are, however, in accordance 
with previous observation by Miyauchi et a1. (1988), where human CGRP induced a 
positive inotropic response in porcine ventricular tissue. Moreover, our observations are 
also compatible with observation that human a~CORP increases cardiac output in 
aneasthesized pig (Van Gelderen et aI., unpublished). 
In literature, evidence has been presented that the positive inotropic and chronotropic 
effects in the atrium of several species, including humans, are mediated via specific CORP 
receptors coupled to adenylyl cyclase (Franco-Cereceda et aI., 1987; Miyauchi et aI., 1987; 
Ono et aI., 1989; Anand et aI., 1991). In the heart, specific binding sites for CGRP linked 
to stimulation of adenylyl cyclase activity have been identified. Whereas these binding 
sites reach high concentrations in the rat atrium (Oennari et al., 1985; Sigrist et aI., 1986), 
such sites in the ventricles from guinea pig are scarce (Ishikawa et aI., 1988). This may 
explain the lack of response in the ventricular muscle of most species, including humans. 
However, the results from the present study in porcine hemi indicate the opposite: a 
substantial response in ventricular tissue, but not in atrial tissue. At least two possibilities 
for the discrepancy can be discussed. Firstly, the specific binding sites for CGRP may be 
absent in the porcine atrium, but present in the ventricle. Although no data are available 
about specific binding sites for CGRP in porcine atrium, these sites have been 
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demonstrated in porcine ventricular tissue (Miyauchi et aI., 1988). Secondly, CGRP may 
be species-specific. CGRPs from different species have a slightly different amino acid 
sequence, For instance, the human CGRP, where the amino acid sequence differs from 
that of the rat CGRP at four positions, showed different potency in increasing the heart rate 
of guinea-pig atrium (Marshall et aI., 1986). In this regard, we cannot exclude that if 
porcine CGRP (not available yet) had been used in the porcine tissue, this would mimic the 
effects in human tissue. If the latter possibility would be true, it is interesting to 
investigate the effect of porcine CORP in human myocardium. 
In the present study, porcine isolated myocardium showed a different response to 
human CORP, compared to most other species, including human. In combination with our 
previous investigations in porcine isolated myocardium (Schoemaker et al,1993, Du et aI., 
1993), we conclude that although the basic response and mechanisms in cardiac 
contractility derived from investigation in porcine heart may be applicable to the human 
heart, results from the present study suggest that this model, too, has its limitations. 
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6.1 Summary 
Different pharmacological responses of atrium 
and ventricle: 
tissue 
studies with human cardiac 
It has been recently reported that S~hydroxytryptamine (5-HT) increases force of contraction 
in atrial tissue but not in ventricular tissue. In the present study with trabeculae obtained from 
non-diseased human hearts, we investigated whether this difference in the contractile responses is 
specific for 5-HT or is also observed for other substances: calcitonin gene-related peptide (CORP), 
angiotensin n, adenosine, somatostatin and acetylcholine. CORP (10.9.10.7 M) and angiotensin II 
(IO·9·IO·S M) caused concentration-dependent increases in force of contraction in atrial trabeculae (up 
to 36±8% and 42±8% of the response to 10.5 M noradrenaline, respectively). Similar to 5-HT, no 
effects were observed with CORP and angiotensin II in ventricular trabe<:ulae. Adenosine (lO's to 
10'$ M) and somatostatin (to,S to 10.6 M) caused concentration-dependent negative inotropic effects 
on baseline atrial contractility (-54± 17% and -5l±25%, respectively), but no response was found on 
baseline ventricular contractility. Adenosine, but not somatostatin, reduced force of contraction after 
pre-stimulation with 10'$ M noradrenaline in atrial tissue and, to a lesser extent, in ventricular tissue. 
Acetylcholine exhibited a biphasic concentration-response curve in the atrial tissue, consisting of an 
initial negative inotropic response (10'9_10'7 M, from 120±41 rug at baseline to 48± 16 mg at 10'7 M), 
followed by a positive inotropic response (l0·6-IO'} M, from 48±16 mg at to-7 M to 77±15 mg). On 
the baseline ventricular force of contraction, acetylcholine (10'9_10-4 M) induced only a positive 
inotropic effect, starting at 10,9 M (from 252±65 mg at baseline to 353±71 mg at 10-4 M), After 
pre-stimulation with 10,$ M noradrenaline, acetylcholine reduced force of contraction in both tissues 
at to'} M (atrium: -14±4%, ventricle: -6l±S%). The data indicate that, in atrial tissue, force of 
contraction can be affected by either positive or negative inotropic agents. However, in ventricular 
tissue only positive inotropic effects could be detected. Since atrial and ventricular tissues display 
different responses to the above biogenic substances, a different mechanism of regulation of 
contractility seems feasible. 
6.2 Introduction 
In humans the B-adrenoceptor-G,-protein-adenylyl-cyclase pathway is the most powerful 
mechanism for the regulation of cardiac contractility. By using either the same or alternative 
pathways, several other biogenic substances can also affect cardiac contractility} and hence} 
they may also be involved in the regulation of cardiac function. Substances that evoke 
positive inotropic effects include 5-hydroxytryptamine (5-HT) (mediated by 5-HT, receptor; 
Kaumann et aI., 1991; Schoemaker et aI., 1993; Zerkowski et aI., 1993), histamine (mediated 
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mainly by H, receptor; Bristow et aI., 1982; Du et aI., 1993; Zerkowski et aI., 1993), 
vasoactive intestinal peptide (VIP) (mediated by VIP receptor; Hershberger et aI., 1989), 
angiotensin II (mediated by angiotensin AT, receptor; Urata et aI., 1989; Zerkowski et aI., 
1993) and endothelin (mediated by ETA receptor; Brodde et aI., 1992). Substances that evoke 
negative inotropic effects include adenosine (mediated by adenosine AI receptor; Hershberger 
et aI., 1987), somatostatin (mediated via somatostatin receptors; Hershberger et aI., 1988), and 
acetylcholine (mediated by M, receptor; Brodde et aI., 1992). 
It has been recently reported that 5-HT increases the atrial force of contraction without 
affecting the ventricular contraction in the pig (Saxena et aI., 1992; Schoemaker et aI., 1992) 
as well as in humans (Jahnel et aI., 1992; Schoemaker et aI., 1993), thus suggesting that an 
agent can elicit a positive inotropic response in the atrium without having a corresponding 
effect in the ventricles. In this investigation with human heart, we report similar 
characteristics of several other substances - human calcitonin gene-related peptide (CORP), 
angiotensin II, adenosine, somatostatin and acetylcholine. \Ve focused on the comparison of 
the responses of atrial and ventricular tissues obtained, in most cases, from the same 
non-diseased human hearts. To our knowledge, this is the first study to investigate the 
contractile responses of atrial and ventricular tissues from the same heart in parallel. 
6.3 Material and methods 
6.3.1 General preparations 
Right atrial and left ventricular trabeculae were obtained from 42 'beating heart' organ 
donors (27 males, 15 females; age I-54 years) who died of non-cardiac disorders (26 
cerebrovascular accident, 14 poly trauma, I encephalopathy, I hypoxia) less than 24 h before 
the tissue was taken to the laboratory. The hearts were kindly provided by the Rotterdam 
Heart Valve Bank (Bio Implant Services FoundationJEurotransplant Foundation) after removal 
of the aortic and pulmonary valves for homograft valve implantation. The hearts were stored 
at 0-4 °C in a sterile organ protecting solution (UW, Eurocollins, or HTK-Brettschneider; see 
Ploeg et aI., 1992) immediately after circulatory arrest. 
After excision, pieces of atrial and ventricular myocardium were placed in ice-chilled 
oxygenated Krebs buffer (composition in mM: NaCI 118, KCI 4.7, CaCI, 2.5, MgSO, 1.2, 
NaHCO, 25, KHPO, 1.2 and glucose 8.3) and atrial and ventricular trabeculae «I mm 
thickness) were carefully dissected free. The trabeculae were mounted in organ baths (gassed 
with 95% 0, and 5% CO,; 37'C) and then prepared for isometric tension recording with a 
Harvard transducer. Resting tension was set to 750 and 1950 mg for atrial and ventricular 
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tissues, respectively, in order to provide optimal loading conditions. Tissues were paced at 
I Hz, using electrical field stimulation (3 ms, voltage 20% above threshold). 
6.3.2 Experimental protocol 
After stabilization, the baseline force of contraction was measured. A 
concentration-response curve for noradrenaline was obtained to check the inotropic 
responsiveness of the tissues. Since the tissues were irreversibly damaged after a 
concentration of 10" M (the baseline force of contraction decreased after washout and did not 
recover in a reasonable time), the maximum concentration of noradrenaline was restricted to 
10" M. The responses to all other substances are expressed as percentages of either the 
response to 10.5 M noradrenaline or the baseline force of contraction. Tissues with a response 
to 10" M noradrenaline smaller than 25 mg were excluded from further analysis. 
After the tissues had been washed (6 times) and had stabilized, a concentration-response 
curve for CORP (10"_10.7 M), angiotensin II (10"-10" M), adenosine (10"-10" M), 
somatostatin (10"_10" M), or acetylcholine (10"_10') M, in the presence of 10" M 
physostigmine to prevent rapid degradation of acetylcholine by cholinesterase; see Chatonnet 
and Lockridge, 1989) was obtained in parallel in both atrial and ventricular tissues. Only one 
substance was studied per tissue. After another wash and stabilization period, the 
concentration-response curve for adenosine and somatostatin was constructed again following 
pre-stimulation with 10.5 M noradrenaline. Because of desensitization occurring after repeated 
exposure to acetylcholine, the above-described experiments with this substance after 
pre-stimulation with 10" M noradrenaline were carried out in separate tissues. At the end of 
each experiment without pre-stimulation with noradrenaline (except in a few cases where the 
tissue was f!"Ozen for further investigations which are not reported here), another noradrenaline 
concentration-response curVe was obtained after washing and re-stabilization (at least 10 min) 
to check the viability of the tissue. In the case of investigations with adenosine and 
acetylcholine in pre-stimulated (10" M noradrenaline) myocardium, we checked the stability 
of the noradrenaline response by administering 10.5 M noradrenaline at the end of protocol. 
6.3.3 Data presentation and analysis 
All data are presented as means±S.E.M. Baseline values for atrial and ventricular 
tissues were compared by using an unpaired I-test. The effects of noradrenaline, CORP, 
angiotensin II, adenosine, somatostatin and acetylcholine were analyzed by using an analysis 
of variance (ANOV A) for repeated measurements. Differences were regarded statistically 
significant, if P<0.05. 
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6,3.4 Compounds used 
The compounds used in the present study were: noradrenaline bitartrate (Sigma, St. 
Louis, MO, U,S,A.), adenosine (Janssen, Geel, Belgium), angiotensin II, human CGRP and 
somatostatin-14 (Saxon, Hannover, F.R.G.), acetylcholine chloride (Ciba, Breda, The 
Netherlands), atropine sulphate (Centrafarm, Etten-Leur, The Netherlands), physostigmine 
salicylate (Sandoz, Basel, Switzerland) and propranolol hydrochloride (Imperial Chemical 
Industries Limited, Macclesfield, U.K.). 
6.4 Results 
6.4.1 Viability of the tissues 
On average, the baseline force of contraction was significantly lower in atrial tissue 
(l26±25 mg, n=37) than in ventricular tissue (221±34 mg, n=34). In both tissues 
noradrenaline (lO-8MI0-5 M) increased force of contraction in a concentratiollMdependent 
manner. After exposure to 10-5 M noradrenaline, the force of contraction went up to 
548±55 mg (n=37) and 599±78 mg (n=34) in the atrial and ventricular trabeculae, 
respectively. When the response to noradrenaline (10" M) was elicited again at the end of 
the protocol, similar (in atrial trabeculae: 107±IO% of the initial noradrenaline response, 
n=33) or even greater (in ventricular trabeculae: 177±29% of the initial noradrenaline 
response. n=31) increases in force of contraction were observed. 
6.4.2 Positive inotropic effects 
6.4,2.1 CGRP. An example of the recordings obtained from the atrial and ventricular 
trabeculae is shown in figure 6.1. Unlike noradrenaline, CGRP increased force of contraction 
in atrial but not in ventricular tissue. The mean results are shown in figure 6.2 (left panel). 
CGRP (10"-10.7 M) exerted a positive inotropic effect in a concentration-dependent manner 
in the atrial tissue. At 10.7 M CGRP, force of contraction increased significantly from 
374±128 mg at baseline up to 545±151 mg, or 36±8% of the response to 10" M noradrenaline 
(n=8). In contrast, no significant change was noticed in the ventricular force of contraction 
(baseline: 356±73 mg, 10.7 M CGRP: 374±79 mg, n=8). 
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Figure 6.l. Recordings of force of contraction of a right atrial (top) and a left ventricular (bottom) 
trabecula showing the effects of cumulative concentrations of CORP as compared to those of 
noradrenaline (NA), before and after CORP. 
6.4.2.2 Angiotensin lIOn average angiotensin II (10-' M to 10·' M) caused a 
concentration-dependent increase in the atrial force of contraction) but 2 out of 6 atrial 
trabeculae (33%) did not respond to angiotensin II. Data from the other 4 trabeculae (67%) 
showed an enhanced force of contraction, which increased from 70±50 mg at baseline to 
398±117 mg with 10-' M angiotensin 11 (see figure 6.2, right panel). No response was seen 
in any of the 5 ventricular trabeculae. 
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Figure 6.2. Cumulative concenlratiolHesponse curves of CORP and angiotensin II in atrial and 
ventricular trabeculae (CORP: n=8 each; angiotensin II: n=4 and 5 for atrium and ventricles, 
respectively). Responses to both compounds are expressed as percentages of the response to 10.5 M 
noradrenaline (NA). 
6.4.3 Negative inotropic effects 
6.4.3.1 Adenosine. The effects of adenosine (10"-10" M) on the atrial and ventricular 
force of contraction at baseline or in the presence of 10's M noradrenaline are presented in 
figure 6.3, In the atrial tissue, adenosine significantly reduced baseline force of contraction 
(from 116±57 mg to 58±40 mg at 10" M; n~5), as wcll as force of contraction in the 
presence of 10" M noradrenaline (503±134 mg to 317±114 mg at 10" M; n~6). In the 
ventricular tissue, adenosine did not affect baseline contractility (baseline: 86±30 mg, 10's M 
adenosine: 93±30 mg; n~5) and only slightly (but significantly) decreased force of contraction 
after pre-stimulation with 10" M noradrenaline (from 657±140 mg down to 597±137 mg, at 
10" M; n~6). 
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Fign1e 6.3. Concentration-response curves of adenosine on the baseline force of contraction (11=6) and 
on the force of contraction after pre-stimulation with to'$ M noradrenaline (NA; 11=5), obtained with 
atrial and ventricular tissues. 
6,4,3.2 Somatostatin. The mean results from 5 pairs of atrial and ventricular trabeculae 
are shown in figure 6.4. Over a concentration range of 10,8·10,6 M, somatostatin decreased 
the atrial baseline force of contraction from 464±184 mg to 180±124 mg (-51±25%) at 
10.6 M, but it did not affect the atrial force of contraction after pre-stimulation with 10" M 
noradrenaline (928±83 mg before and 936±95 mg after 10'6 M somatostatin). Neither at 
baseline nOf after pre-stimulation with noradrenaline did somatostatin affect ventricular 
contractility. 
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Figure 6.4. Concentration-response curves of somatostatin on the basel inc force of contraction (11=5) 
and on the force of contraction after pre-stimulation with IO's M noradrenaline (NAj n=5), obtained 
with atrial and ventricular tissues. 
6.4.4 Mixed inotropic effects of acetylcholine 
An example of recordings showing the effects of acetylcholine on the right atrial and 
left ventricular trabeculae is presented in figure 6.5. In the atrial trabecula, acetylcholine 
elicited a biphasic effect, consisting of an initial negative inotropic response (from 
10"_10.1 M) followed by a positive inotropic response (from 10"_10.4 M). It should be noted 
that even after the highest concentration of acetylcholine (10') M) the force of contraction did 
not exceed the baseline value. In the ventricular trabecula, acetylcholine caused a clear 
concentration-dependent positive inotropic effect. After administration of 10's M 
noradrenaline, which resulted in a stable increase in the atrial and ventricular force of 
contraction, acetylcholine produced only negative inotropic effects in both tissues. 
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Figure 6.5. Recordings of force of contraction of two right atrial (top 2 panels) and two left 
ventricular (bottom 2 panels) trabeculae obtained from the same hearts. The recordings show the 
effects of cumulative concentrations of acetylcholine (in the presence of 10,5 M physostigmine) on the 
baseline force of contraction (first and third panels) and after pre-stimulation with 10's M noradrenaline 
(NA; second and fourth panels), For comparison, the sustained effect of stimulation with 10'5 M 
noradrenaline is also presented. 
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The mean results of the effects of acetylcholine on the atrial and ventricular baseline 
force of contraction are shown in figure 6.6 (left panel). In the atrial tissue, at low 
concentrations acetylcholine decreased baseline force of contraction from l20±4l mg to 
48±16 mg (-50±11%) at 10.7 M (n~8), whereas in concentrations above 10" M, acetylcholine 
increased force of contraction (up to 77±15 mg at 10') M; n~8) back towards baseline values. 
In the ventricular tissue, acetylcholine increased baseline force of contraction in a 
concentration-dependent manner (maximal response 358±70 mg or 56±16% increase from 
baseline at 10" M; n~6). Figure 6.6 (right panel) presents the mean results of the effects of 
acetylcholine on force of contraction after pre-stimulation with 10·s M noradrenaline. At 
10') M, acetylcholine reduced the atrial (n~7) and ventricular (n~6) force of contraction from 
504±14l mg and 463±93 mg, respectively, to 43±6 mg (14±4%) and 288±59 mg (61±5%), 
respectively. 
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Figure 6.6. Concentration-response curves of acetylcholine on the baseline force of contraction and 
on the force of contraction after pre-stimulation with 10.5 M noradrenaline (NA) in atrial and 
ventricular tissues. The number of atrial and ventricular trabeculae lIsed were: 8 and 6, respectively, 
in the left panel; and 7 and 6, respectively, in the right panel. 
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6.5 Discussion 
Recent investigations have established that 5-HT, which increases heart rate and atrial 
contractility in both porcine (Saxena, 1986; Bom et aI., 1988; Kaumann, 1990; Villalon et aI., 
1990) and human (Kaumruill et aI., 1990, 1991) heart by acting at 5-HT4 receptors, does not 
have a direct effect on ventricular contractility (Jahnel et aI., 1992; Saxena et aI., 1992; 
Schoemaker et aI., 1992, 1993). Therefore, the main purpose of the present investigation was 
to establish whether or not such a differential effect is also noticed with other biogenic 
substances in atrial and ventricular trabeculae obtained from the same non-diseased human 
heart. Since the adenylyl cyclase/cAMP pathway is the major system regulating force of 
cardiac contraction (Bradde et aI., 1992), noradrenaline was used to check the inotropic 
responsiveness and viability of the tissues, both at the beginning and at the end of the 
experiments. As in our previous studies (Du et aI., 1993; Schoemaker et aI., 1993), tissues 
not responding to noradrenaline at the beginning of the experiment were excluded. AU tissues 
responded to noradrenaline at the end of experiment, confirming that these tissues remained 
viable during the course of the experiment. 
6.5.1 Positive inotropic effects 
CORP, a neuropeptide released by the endings of sensory nerve fibres, exerts a positive 
inotropic effect on atrial but not on ventricular myocardium of the rat (Sigrist et aI., 1986; 
Ishikawa et aI., 1987) and guinea-pig (Saito et aI., 1987; Ishikawa et aI., 1988; Giuliani et aI., 
1992). In both species the atrial effect of CORP is associated with an increase in cAMP 
(Sigrist et aI., 1986; Ishikawa et aI., 1988). In the dog, CORP (up to I flM) has no effect on 
either the atrial or ventricular trabeculae (Rigel et aI., 1989). In the human myocardium, a 
positive inotropic effect has been reported on the atrial tissue (Franco·Cereda et aI., J 987), 
but no data are available about the effect of CORP on the ventricular contractility. Qur 
results show that, similar to the rat and guinea'pig, a positive inotropic effect of CORP was 
observed in human atrial trabeculae. However, CORP had no effect on ventricular tissue 
obtained fram the same heart. As was the case with 5-HT (Schoemaker et aI., 1993), the lack 
of effect of CORP on the ventricular myocardium was not due to deterioration of the tissue 
during the experiment. Animal studies have shown that specific binding sites for CORP can 
be identified in high concentration in the atrium (Sigrist et aI., 1986), but such sites are scarce 
in the ventricles (Ishikawa et aI., 1988). Therefore, a low receptor density may explain the 
lack of response in the ventricular muscle. 
As has been reported earlier (Urata et aI., 1989; Moravec et aI., 1990; Zerkowski et aI., 
1993), angiotensin II did increase atrial contractility in our experiments, though not all atrial 
preparations responded to this peptide. In addition, our experiments show that angiotensin 
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did not affect human ventricular contractility. Though Moravec et al. (1990) reported that 
angiotensin II has a positive inotropic effect on human ventricular trabeculae, the responses 
in the atrium were more pronounced. The reason for this difference is not clear, but it may 
be related to the heterogeneous receptor distribution in the human myocardium (Urata et aI., 
1989). The effects of angiotensin II on atrial tissue are mediated by angiotensin AT, receptors 
(Pieske et aI., 1993; Zerkowski et aI., 1993), which are coupled to the production of 
phospholipase C/diacylglycerol from inositol-I,4,5-trisphosphate (Brodde et aI., 1992; 
Zerkowski et aI., 1993). Thus, the discrepancy between atrial and ventricular contractile 
responsiveness is not restricted to adenylyl cyclase/cAMP mediated mechanisms. 
6.5.2 Negative inotropic effects 
Adenosine elicited a negative inotropic effect on the baseline as well as 
noradrenaline~stimulated atrial contractility, but it had no (baseline) or little 
(noradrenaline~stimulated) effect on ventricular contractility. Adenosine as well as some of 
its analogues have been shown to inhibit isoprenaline-stimulated force of contraction in 
ventricular myocardium at concentrations above 10.5 M (Bohm et aI., 1985; Jakob et aI., 
1989). The negative inotropic effect of adenosine seems to be mediated by A, receptors, 
which are negatively coupled to adenylyl cyclase and have been identified in both human 
atrial and ventricular myocardium (B5hm et aI., 1985; Hershberger et aI., 1987; Schmitz et 
aI., 1987). However, in human atrial tissue, the density of the AI receptors is about twice as 
high as in ventricular tissue (B5hm et aI., 1989), which could offer an explanation for the 
difference in the pharmacological responses of the atrium and ventricle. 
Somatostatin exerted a concentration-dependent negative inotropic action on the baseline 
atrial force of contraction. No effect was noticed on the noradrenaline-stimulated atrial 
trabeculae or on the ventricular trabeculae, with or without stimulation with noradrenaline, 
despite a report that somatostatin may inhibit adenylyl cyclase activity in the human 
ventricular myocardium (Hershberger et aI., 1988). Somatostatin is suggested to act via a 
receptor that is negatively coupled to the adenylyl cyclase pathway via G;-proteins (Brodde 
et aI., 1992). In atrial fibres, the inhibitory effect of somatostatin on contractility was 
associated with a reduction of intracellular calcium (Hou et aI., 1987). The concentration of 
somatostatin in the atrioventricular node and right atria was found to be significantly higher 
than in other heart regions (Day et aI., 1985), suggesting that somatostatin has a role in the 
cardiac conduction system rather than in the direct regulation of ventricle contractility. The 
lack of a negative inotropic effect on ventricular contractility is apparently an optimistic sign 
from the point of the clinical use of somatostatin. Thus, for example, long-term (3~6 months) 
treatment with this drug has been reported to reverse left ventricular hypertrophy and improve 
exercise performance in acromegalic patients (Tokgozoglu et aI., 1993). 
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6.5.3 Mixed inotropic effects 
Acetylcholine caused a mixed positive and negative inotropic response in the present study. 
Both negative (at concentrations <10.6 M) and positive (at concentrations <:10.6 M) inotropic 
effects of acetylcholine and other cholinergic agonists have been found in isolated atrial tissue 
from several animal species, including rabbit (Endoh and Blinks, 1984) and chick (Tajima et 
aI., 1987), as well as rat and guinea-pig (Eglen et aI., 1988). In ventricular tissue, only a 
positive inotropic effect on baseline contractility (started at 10" M) and a negative inotropic 
effect (though weaker than in the atrial tissue) after pre-stimulation with noradrenaline were 
seen. The negative inotropic effect is consistent with findings reported in the literature (see 
Jakob et aI., 1989); the effect depends on the presence of drugs that increase force of 
contraction by augmenting cellular cAMP (Korth and KUhlkamp, 1987; LOffelholz and 
Pappano, 1987). In most species, the positive inotropic effect of muscarinic agonists in 
ventricular tissues is only seen at concentrations above 10" M (Korth and KUhlkamp, 1987; 
Tsuji et aI., 1987). However, our results are consistent with a report by Oilmour and Zipes 
(1985) that acetylcholine elicits a positive inotropic response at concentrations ranging from 
10"_10" M in canine cardiac Purkinje fibres. Both the positive and the negative inotropic 
effects could be antagonized by atropine (Du et aI., unpublished observations), indicating the 
involvement of muscarinic receptors. In the human heart, M2-receptors are predominantly 
present (Brodde et aI., 1992) and these seem to exist in two different states (Brown and 
Brown, 1984): a high-affinity state associated with inhibition of adenylyl cyclase causing 
negative inotropy (Korth and KUhlkamp, 1987; Eglen et aI., 1988; Brodde et aI., 1992), and 
a low affinity state, coupled to a pertussis toxin insensitive 0 protein to stimulate 
inositol-I,4,5-trisphosphate hydrolysis (Poggioli et aI., 1986; Tsuji et aI., 1987; Eglen et aI., 
1988), causing positive inotropy. This hypothesis provides a good explanation for the 
biphasic response in atrial tissue. In ventricular tissue, these high- and low-affinity states 
might also exist, but in most species only the latter is expressed, so that acetylcholine has 
predominantly a positive inotropic effect. 
In conclusion, data from the present study show that several endogenous substances 
(CORP, angiotensin II, adenosine, somatostatin and acetylcholine) exhibit different effects on 
atrial and ventricular contractility. In general, atrial tissue shows more marked responses than 
ventricular tissue. Although the effects and the mechanisms of the above substances are 
different, in the end these substances affect Ca" influx. Fabiato (1982) has suggested that, 
in many mammalian species, the Ca2+-induced release ofCa2+ is more developed in the atrium 
than in the ventricle. This implies that the atrium is more sensitive than the ventricle to 
substances that modify Ca2+ influx. Therefore, a low sensitivity to Ca2+ -induced release of 
Ca2+, as well as a lower density or absence of the involved receptors, may be responsible for 
the poor ventricular responses to these agents. The results of this study may help provide a 
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better understanding of the physiology of atrial and ventricular contractility, as well as an 
important direction for drug development. 
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7.1 SUlllmary 
Characterization of the positive and negative 
inotropic effects of acetylcholine in human 
isolated atrial and ventriculm' trabeculae 
In the human isolated myocardium, acetylcholine (l0·9 to to') M) elicited a biphasic inotropic 
effect (a decrease in the lower and an increase in higher concentration range) in atrial and a 
positive inotropic effect in ventricular trabeculae, However, under conditions of raised contractility 
achieved by exposure to noradrenaline (10.5 M), negative inotropic effects ,vere observed in both 
atria and ventricles. Atropine (10.6 M), but not propranolol (10.6 M), antagonized both the positive 
and negative inotropic effects of acetylcholine, thus showing that the responses were mediated by 
muscarinic acetylcholine receptors. The lise of subtype selective muscarinic receptor antagonists 
(10" to 10" M), pirenzepine (M,>M,>M,), AF-DX 116 (M,>M,>M,) and HHSiD (M,;~lvl,»M,), 
revealed that the negative inotropic effect of acetylcholine in atrial as well as the positive inotropic 
effect in ventricular trabeculae were best antagonized by AF~DX 116 and not by pirenzepine, 
suggesting the involvement of the muscarinic M2 receptor subtype, possibly linked to different 
second messenger systems. On the other hand, the positive inotropic effect of acetylcholine (10.6 to 
10.1 M) in the atrial tissue, observed only in preparation with depressed contractility, was not 
effectively antagonized by either AF~DX 116 or HHSiD, but was significantly reduced by 
pirenzepine. Furthennore, the muscarinic M\ subtype selective agonist McN~A~343 (10.9 to 
10.1 M), which failed to significantly change the baseline contractility in either atrial or ventricular 
trabeculae, produced a positive inotropic effect in atrial preparations when contractility had been 
depressed by prior treatment with acetylcholine (l0·9 to 10.7 M). This effect of McN~A~343 was 
effectively antagonized by pirenzepine (l0·5 M). These data show that, besides the muscarinic M2 
receptor mediating both negative (atria) and positive (ventricle) inotropic effects, muscarinic Ml 
receptors, capable of reversing depressed atrial contractility, are also present in the human heart. 
7.2 Introduction 
It is well known that acetylcholine causes negative inotropic and chronotropic effects 
in the mammalian heart, including humans (8rodde et aI., 1992; Caulfield, 1993; B61m1 
et ai., 1994; Landzberg et ai., 1994). In addition, studies have shown that acetylcholine 
can elicit a positive inotropic response in isolated cardiac tissue of some species (Endoh 
and Blinks, 1984; Tajima et ai., 1987; Eglen et ai., 1988). In our previous study in 
isolated human myocardium, we reported that acetylcholine elicited a biphasic response (an 
initial decrease followed by an increase in contractility back to baseline values) in the atrial 
trabeculae, whereas only a positive inotropic effect was noticed in the ventricular 
trabeculae (Du et ai., 1994). This latter effect was not observed earlier (Jakob et ai., 1989; 
Deighton et ai., 1990; Bahm et ai., 1994). 
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Five muscarinic acetylcholine receptor subtypes genes have been cloned and 
expressed, but only muscarinic M2 receptors have been detected in the human heart (Maeda 
et aI., 1988; Ford et aI., 1992; Caulfield, 1993). Correspondingly, the responses to 
muscarinic receptor agonists in the cardiac muscle appear to be mediated by the activation 
of a well-characterized muscarinic M2 receptor, which are coupled to different signal 
transduction pathways (Schimerlik, 1989). However, the cardiac effects of muscarinic 
receptor stimulation are not yet fully understood and evidence is emerging that, besides the 
muscarinic M2 receptor, other muscarinic receptor are also expressed in the heart. For 
example. muscarinic M] receptors seem to mediate positive inotropic effects in cells 
isolated from adult guinea-pig ventricles (Gallo et aI., 1993) as well as the increase in 
automaticity in canine Purkinje fibres (Rosen et aI., 1990). Thus, it is suggested that 
although the predominant popUlation of muscarinic receptors at postsynaptic sites in the 
heart is of the muscarinic M2 subtype, a small population of muscarinic M] subtype is also 
present (Watson et aI., 1983; Evans et aI., 1985). 
The purpose of the present study was to characterize the receptors involved in the 
observed inotropic effects of acetylcholine in the human cardiac tissue (Du et aI., 1994) by 
using relatively selective antagonists at the muscarinic M]. M2 and M,l receptors (Doods 
et al.. 1987) as well as a selective muscarinic agonist at the muscarinic M] receptor. 
7.3 Material and methods 
7.3.1. Preparations 
Right atrial and left ventricular trabeculae were obtained from 61 heart beating organ 
donors (43 males, 18 females aged 2-55 years), who died of non-cardiac disorders (36 
cerebrovascular accident, 20 polytrauma, 5 hypoxia) less than 24 h before the tissue was 
brought to the laboratory. The hearts were kindly provided by the Rotterdam Heart Valve 
Bank (Bio Implant Services Foundation/Eurotransplant Foundation) after removal of the 
aortic and pulmonary valves for homograft valve implantation. The hearts were stored at 
0-4°C in a sterile organ protecting solution (UW, Eurocollins, or HTK-Brettschneider, see 
Ploeg et al. 1992) inunediately following circulatory arrest. After excision, tissue samples 
were placed in ice-chilled oxygenated Kreb's buffer (composition in Mill: NaCI 118, KCI 
4.7, CaCI, 2.5, MgSO, 1.2, NaHCO, 25, KHPO, 1.2 and glucose 8.3) and atrial and 
ventricular trabeculae «I Illm thickness) were carefblly dissected free. The trabeculae 
were mounted in organ baths containing Kreb's buffer (37°C, gassed with 95% O2 and 5% 
CO,) and paced at I Hz using electrical field stimulation (3 ms, voltage 20% above 
threshold). The developed tension was recorded using isometric Harvard transducers and 
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Goerz flatbed recorders (Schoemaker et aI., 1993; Du et aI., 1994). Based on preliminary 
experiments, the chosen optimal resting load, yielding the highest developed tension, was 
750 mg and to 1950 mg for atrial and ventricular tissue, respectively. 
7.3.2 Experimental protocol 
After stabilization, resting tension and baseline contractile force were measured. A 
concentration-response clirve for noradrenaline was obtained to check the viability of the 
tissues (Schoemaker et aI., 1993; Du et aI., 1994). Tissues with less than 25 mg response 
to 10·s M noradrenaline were excluded from further analysis. 
After washing (6 times) and stabilization, 10" M physostigmine was added to the 
Kreb's buffer in experiments involving acetylcholine to prevent its rapid degradation by 
cholinesterase (see Chatonnet and Lockridge, 1989). One cumulative concentration respon-
se curve for acetylcholine (10" to 10" M) was constructed in each atrial and ventricular 
preparation, in the absence (control) or after 30 min incubation with one of the following 
antagonists: propranolol (10" M, non-selective ll-adrenoceptor antagonist), atropine (10.6 M, 
non-selective muscarinic receptor antagonist), pirenzepine (10-7, 10-6 or lO-s M, muscarinic 
M, receptor antagonist, Hanuner et aI., 1980), AF-DX 116 (10", 10" or 10" M, muscarinic 
M, receptor antagonist, Giachetti et aI., 1986) and HHSiD (10" or 10" M, muscarinic M, 
receptor antagonist, Lambrecht et aI., 1989). In addition, the effects of acetylcholine on 
trabeculae pre-stimulated with noradrenaline (10" M) were investigated either in the 
absence or presence of 10-6 M atropine. 
Since not all effects of acetylcholine could be fully explained after the use of 
antag'onists, we also investigated the effects of a muscarinic MJ receptor agonist, 
McN-A-343. One cumulative concentration response curve for McN-A-343 (10" to 
10.3 M) was obtained in each atrial and ventricular preparation. In addition, in the atrial 
tissue, cumulative concentration response curves for McN-A-343 (to·9 to 10-3 M) were also 
constructed following a maximal negative inotropic effect induced by acetylcholine (10" to 
;, 10" M), in the absence or presence of pirenzepine (10" M). 
There was no apparent difference in the responses to noradrenaline or acetylcholine 
observed in trabeculae obtained from subjects of different age or dying from different 
causes. This is also true for a number of other substances, including 5-hYdroxytryptamine 
and histamine (Schoemaker et aI., 1992; Du et aI., 1993, 1994). 
7.3.3 Data presentation and analysis 
Data are presented as meansiS.E.M. Baseline values for atrial and ventricular tissue 
were compared using an unpaired t-test. The effects of acetylcholine and McN-A-343 in 
the absence or presence of various antagonists were analyzed using an analysis of variance 
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for repeated measurements. Differences were regarded statistically significant, if p~0.05. 
Since the negative inotropic response in atrial and the positive inotropic response in 
ventricular tissues reached their maximum, the curves were fitted to a four parameter 
logistic function (Lean et aI., 1978) to calculate, where applicable, apparent pD, values 
(negative logarithm of the molar concentration eliciting half maximum effect). Apparent 
pKn values were derived from pD2 values, using the following equation: 
pKB =-Log[B] + Log{([A,]/[A,])-I), where [B] is the molar concentration of antagonists 
and [Aa and [A,] represent molar concentrations of agonists eliciting half maximal effect 
in the absence and presence of antagonists, respectively. 
7.3.4 Chemicals IIsed 
The chemicals used in the present study were: acetylcholine chloride (Ciba, Breda, 
The Netherlands), AF-DX 116 (11-( {2-[( diethylamino )-methyl]-I-piperidyl }acetyl)-5, 11-
dihydro-6H-pyridol[2,3-b][I,4] benzodiazepine-6-one base; Thomae, BiberachlRiss, 
Germany), atropine SUlphate (Centrafarm, Etten-Leur, The Netherlands), HHSiD (p-
f1uorohexahydro~siladifenidol hydrochloride; Research Biochemicals Incorporated, Natick, 
USA), McN-A-343 (4-(m-chlorophenylearbamoyloxy)-2-butynyltrimethylammonium 
chloride; McNiel, Fort Washington, PA, USA), noradrenaline bitartrate (Sigma, St. Louis, 
MO, U.S.A.), physostigmine salicylate (Sandoz, Basel, Switzerland), pirenzepine base 
(Thomae, BiberachlRiss, Germany), propranolol hydrochloride (Imperial Chemical 
Industries Limited, Macclesfield, U.K.). Drugs were dissolved in distilled water. 
7.4 Results 
7.4.1 Viability of the tisslles 
Baseline contractile force was significantly lower in the atrial (97±13 mg, n=57) than 
in ventricular (236±30 mg, n=54) tissue. In both tissues, noradrenaline (10-' M to 10" M) 
increased contractile force in a concentration-dependent manner. After exposure to 10.5 M 
noradrenaline, the force of contraction went up to 381±35 mg (n=57) and 627±65 mg 
(n=54) in the atrial and ventricular trabeculae. respectively. 
7.4.2 Inotropic responses to acetylcholine in atrial and ventricular trabeculae 
7.4.2.1 Effect on baseline contractility. The effect of acetylcholine on the baseline 
atrial and ventricular contractility as well as the influence of atropine and propranolol are 
shown in figure 7.1. In right atrial trabeculae, acetylcholine exhibited a biphasic 
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contractile response consisting of an initial negative inotropic response followed by a 
positive inotropic response. At low concentrations (10" to /0.7 M), acetylcholine clearly 
decreased the baseline contractile force (maximum decrease from baseline: 67±13% at 
10.7 M), but with higher concentrations the contractile force started to increase towards 
baseline values (0±23% change from baseline at /0') M). If after exposure to /0.7 M 
acetylcholine higher concentrations of acetylcholine were not used, the contractile force 
remained depressed without coming back towards baseline values. However, when 10-4 M 
acetylcholine was administrated without the preceding part of the concentration response 
curve, no positive inotropic effect was observed (data not shown). In contrast to atria, 
acetylcholine caused only a positive inotropic effect in left ventricular trabeculae. The 
maximum increase in contractile force (53±17% from baseline) was observed at 10') M. 
Right atrium Left ventricle 
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Figure 7.1. Cumulative concentration-response curves of acetylcholine (Ach) on the baseline force 
of contraction, obtained in the atrial (left panel) and ventricular (right panel) trabeculae in the 
absence (0, n=5 and 6, respectively) or presence of 10-6 M atropine (A, n=6 each) or propranolol 
(D, n=7 and 6, respectively). 
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Atropine (10-' M) effectively antagonized both the negative and positive inotropic 
effects of acetylcholine in atrial as well as the positive inotropic effect in ventricular 
trabeculae. Since in the presence of atropine a complete concentration-response curve to 
acetylcholine could not be constructed, pD, values of acetylcholine were not calculated. 
However, from figure 7.1 it can be seen that atropine shifted the concentration-response 
curve to the right by more than 3 and 4 log units in atrial and ventricular trabeculae, 
respectively. Propranolol (10" M) did not modify the responses to acetylcholine. 
7.4.2.2 Effect on noradrenaline-stimulated contractility. In the presence of 
noradrenaline (10" M), acetylcholine produced only a negative inotropic effect in both 
atrial and ventricular trabeculae (figure 7.2). The reduction of the contractile force by 
10-3 M acetylcholine was from 504±141 to 43±6 mg (86±4%) in atrial trabeculae (n=7) and 
from 463±93 to 288±59 mg (39±5%) in ventricular trabeculae (n=6). The pD, value for 
acetylcholine was 7.0±0.6 (n=5) and 6.8±0.9 (n=6) in the atrial and ventricular tissues, 
respectively. 
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Figure 7.2. Cumulative concentration-response Clirves of acetylcholine (Ach) on force of 
contraction after pre-stimulation with noradrenaline (NA; I O·~ M), obtained in the atrial (left panel) 
and ventricular (right panel) trabeculae in the absence (0. n=7 and 6, respectively) or presence of 
atropine (10.6 M; A, n=7 and 5, respectively), 
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Figure 7.3. Cumulative concentration-response curves of acetylcholine (Ach) on baseline force of 
contraction in the atrial trabeculae in the absence or presence of antagonists. Upper left panel: 
acetylcholine alone (0=16) or in the presence of pirenzepine (10'1, 10'6 and JO's Mj n=6, 8 and 6, 
respectively). Upper right panel: acetylcholine alone (0=16) or in the presence of AF-DX 116 10.7, 
10.6 and to,S M; 0=6, 8 and 6, respectively), Lower left panel: acetylcholine alone (0=10) or in the 
presence of HHSiD (10--6 and 10.5 M; 0=6 each). 
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Atropine shifted the concentration-response curve for acetylcholine to the right in 
both atrial and ventricular tissue following pre-stimulation with 10.5 M noradrenaline 
(figure 7.2). The pD, values for acetylcholine were decreased in both atrial (4.5±0.1; n~7) 
and ventricular (4.8±0.3; n~5) trabeculae. 
Table 7.1. Maximum negative (with apparent pD2) and positive inotropic eFfects in atrial and 
maximum positive inotropic effect (with apparent pD2) in ventricular trabeculae induced by 
acetylcholine. 
Antagonist 
Control 
Pirenzepine 
Pirenzepine 
Pirenzcpine 
Control 
AF-DX 116 
AF-DX 116 
AF-DX 116 
Control 
HHSiD 
HHSiD 
Atrium 
pM n Negativea pD2 Positiveb 
16 47±12 6.8±0.2 78±11 
0.1 6 73±10 7.1±0.2 29±15+ 
8 61±7 6.4±0.2 37±1 1+ 
10 6 58±6 6.3±0.2 4±3+ 
16 66±5 6.8±0.2 68±12 
O. I 6 67±1 I 6.6±0. I SO±23 
I 8 57±20 5.9±0.2+ 47±37 
10 6 #+ #+ 111±51 
10 70±7 7.l±0.2 75±30 
6 69±6 6.8±O.1 51±31 
10 6 31±28+ 6.4±OA 106±57 
Ventricle 
n PositiveC pD2 
14 33±6 5.6±0.4 
5 37±5 6.3±0.2 
4 56±16 5.1±0.6 
7 50±20 4.7±1.8 
16 46±13 5.8±0.2 
6 38±9 6.1±0.1 
6 26±11 4.8±0.6 
7 29±12 3.9±0.1+ 
10 36±6 6.2±0.3 
6 44±12 6.0±0.2 
5 32±10 5.3±0.4 
a, Change from baseline values by acetylcholine (I O~ M or 10'5 M in presence of the two highest 
concentrations of pirenzepine); h, Change by IO'J M acetylcholine, calculated as the difference 
from the maximal negative eFfect (pD2 not calculable); \ Change from baseline values by 
acetylcholine (lO-4 M or 10') M), *, Significantly different from values in control experiments mn 
in parallel. #, Only positive inotropic response. 
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Figure 7.4. Cumulative concenlration~response curves of acetylcholine (Ach) on baseline force of 
contraction in the ventricular trabeculae in the absence or presence of antagonists. Upper left 
panel: acetylcholine alone (f}=14) or in the presence of pirenzepine (10.7, 10-6 and 10-5 M; 0=5, 4 
and 7, respectively). Upper right panel: acetylcholine alone (0=16) or in the presence of 
AF·DX 116 10-\ 10-6 and 10.5 Mj 0:=6, 6 and 7, respectively). Lower left panel: acetylcholine 
alone (0=10) or in the presence of HHSiD (10.6 and lO's M; n=6 and 5, respectively). 
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7,4,3 Effect of muscarinic receptor antagonists 011 acelylcholine-induced inotropic 
responses 
7.4,3,] Right atrium. Figure 7,3 presents concentration-response curves to 
acetylcholine in atrial trabeculae in the absence (control) or presence of the three relatively 
selective muscarinic receptor antagonists, whereas the relevant parameters of these curves 
are summarized in table 7.1. The muscarinic M, receptor antagonist pirenzepine (10-', 10-6 
or IO-s M) did not significantly change the negative inotropic effect of acetylcholine (10-' 
to 10-6 M), whereas the positive inotropic effect of acetylcholine (10-6 to 10-7 M) was 
significantly reduced by pirenzepine at the highest concentration (lO-s M; pKn could not be 
calculated). 
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Figure 7.5, Cumulative concentration·response curves of McN·A-343 on baseline force of 
contraction, obtained in atrial (CD) and ventricular (A) trabeculae (11=6 each). 
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Figure 7.6. Recordings of force of contraction in four right atrial trabeculae showing the effects of 
acetylcholine (Ach) in different concentrations. Note that the negative inotropic effect of 
acetylcholine (10.7 M), which was maintained for several min (panel A), was reversed by higher 
concentrations of acetylcholine (panel B) and McN~A-343 (panel C). The reversal of the negative 
inotropic effect of acetylcholine by McN~A"343 was not observed in atrial trabeculae pre-treated 
with pirenzepine (1 O·~ M) (panel D). 
The muscarinic M, receptor antagonist AF·DX ) 16 did not significantly modify the 
negative inotropic effect of acetylcholine at 10.7 M, but 10.6 M AF·DX 116 produced a 
79 
iHuscarinic receptors in human heart 
parallel shift to the right of the acetylcholine curve (apparent pKB: 6.7±0.4; n~8) and 
10" M AF-DX 116 completely abolished the negative inotropic effect. AF-DX 116 either 
did not affect (10.7 and 10" M) or even seemed to increase (10" M) the positive inotropic 
component of the effects of acetylcholine. The preferential muscarinic MJ receptor 
antagonist HHSiD (10" M) failed to modify the effects of acetylcholine, but its higher 
concentration (10" M) reduced the negative inotropic component (apparent pKD: 6.0±0.6; 
n=6), without affecting the positive inotropic component. 
7.4.3.2 Left ventricle. The effects of the muscarinic receptor antagonist on 
acetylcholineRinduced positive inotropic effects in ventricular trabeculae are shown in 
figure 7.4 and table 1. Pirenzepine did not efficiently antagonize the responses to 
acetylcholine; only at 10-5 M pirenzepine, the curve for the acetylcholine seemed to be 
slightly shifted to the right (apparent pKB: 5.7±0.5; n~6). On the other hand, AF-DX 116 
(10-6 and 10.5 M) caused a concentration-dependent antagonism of the responses to 
acetylcholine (apparent pKB: 6.7±0.6 and 6.2±0.3, respectively; n~6 each). HHSiD failed 
to modify the responses to acetylcholine. 
7.4.4 Effects of McN-A-343 
7.4.4.1 Baseline contractility. The effects of McN-A-343 (10" to 10" M), a 
relatively selective muscarinic MI receptor agonist, on baseline contractility in the atrial 
and ventricular trabeculae are presented in figure 7.5. McN-A-343 failed to significantly 
alter the force of contraction in either tissue; the values before and after McN-A-343 
(10" M) were 230±51 and 208±56 mg in atrial trabeculae and 348±139 and 358±130 mg 
in ventricular trabeculae. 
7.4.4.2 Acetylcholine-Indllced depressed contractility in atrialtmbeclilae. Figure 7.6 
presents examples of original tracings showing the effects of acetylcholine and McN-AR 343 
in atrial trabeculae. Acetylcholine (10.7 M) produced a sustained negative inotropic effect 
(panel A), which was reversed by higher concentrations of acetylcholine (> I 0" M; panel B) 
as well as by McN-A-343 (;d 0.8 M; panel C). Pre-treatment of the atrial trabeculae with 
pirenzepine (10" M) antagonized the positive inotropic effect of McN-A-343 (panel D).The 
mean data obtained in atrial trabeculae with McNRA-343 in the absence or presence of 
10-5 M pirenzepine (after maximum negative inotropic effect was reached by low 
concentrations of acetylcholine) are presented in figure 7.7. Acetylcholine decreased the 
baseline contractile force from 868±169 Illg at baseline down to 140±63 mg (-84±5%) at 
10.7 M (n~5). McN-A-343 (10" to 10" M) increased the contractile force back to baseline 
values (902±170 mg at 10" M; n~5) in a concentration-dependent way (pD,: 6.75±0.42). 
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Although pirenzepine (10" M) slightly shifted the acetylcholine curve to the right, it 
strongly antagonized the McN-A-343-induced positive inotropic effect. In the presence of 
pirenzepine, the force of contraction was not changed by McN-A-343 (10.9 to 10.4 M). 
Only at 10') M, McN-A-343 increased the contractility from 67±17 to 2S5±42 mg, close to 
the baseline value (3S0±110 mg) (n~4); the pD, value of McN-A-343 based on the last 
response was 3.56±0.06. The apparent pKB value of pirenzepine against McN-A-343 was 
found to be S.57±0.33 (n~4). 
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Figure 7.7. Cumulative concentration-response curves of McN-A-343 on the force of contraction in 
atrial trabeculae after depression of contractility by acetylcholine (Ach; 10.9 to 10'7 or 10-6 M). 
obtained in the absence (0; (1="5) or presence (.; 11=4) of pircnzepinc (1 O·s M). 
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7.5 Discussion 
7.5.1 Involvement of muscarinic receptor in acetylcholine responses 
The results from the present and previous (Du et aI., 1994) studies show that in the 
human isolated myocardium acetylcholine elicits complex inotropic effects, consisting of a 
biphasic response (decrease followed by increase at high concentrations) in atrial baseline 
contractility and only an increase in ventricular baseline contractility. However, in 
conformity with previous observations (Jakob et aI., 1989; Deighton et aI., 1990; Bohm et 
al., 1994) in isoprenaline-augmented human isolated myocardium, acetylcholine decreased 
the contractility in both atrial and ventricular preparations after prior exposure to 
noradrenaline. The negative inotropic effect of muscarinic cholinergic agents (antagonized 
by atropine) is well known, but their positive inotropic action, though reported in some 
animal species (rat atria, Imai and Ohta, 1982; guinea~pig papillary muscles, Korth and 
KUhlkamp, 1987; guinea-pig atria, Eglen et aI., 1988; chick ventricles, Tsttii et aI., 1987), 
has not been reported in humans (see Jakob et aI., 1989; Deighton et aI., 1990; Bohm et 
aI., 1994). The reasons for this discrepancy are not entirely clear. However, in contrast to 
our investigations performed in non~diseased hearts and with acetylcholine in ventricular 
trabeculae, the previous authors (Jakob et aI., 1989; Deighton et aI., 1990; Bomn et aI., 
1994) studied the effects of carbachol on papillary muscles obtained from hearts removed 
for transplantation surgery. 
The precise receptor mechanisms involved in the positive inotropic effects of 
muscarinic cholinergic agents is not well understood. In the rat atria (Imai and Ohta, 
1982), guinea-pig papillary muscle (Korth and KUhlkamp, 1987) and chick ventricles (Tsttii 
et aI., 1987), the positive inotropic effect was antagonized by atropine and, in the last two 
tissues, it was also shown that the effect, being unaffected by prior reserpinization (Korth 
and KUhlkamp, 1987) or propranolol (Tsuji et aI., 1987), was independent of endogenous 
catecholamines. In accordance with these observations, we also found that atropine not 
only blocked the negative inotropic effect in the atria, but also the positive inotropic 
responses in both atria and ventricles, which were unaffected by propranolol. Thus, the 
results show that both the negative and positive inotropic effects of acetylcholine in the 
human isolated myocardium are mediated by muscarinic receptors. 
7.5.2 Subtypes o/muscar/Ilk receptors involved in acetylchoUne responses 
Although, at present, highly selective antagonists of muscarinic receptor subtypes are 
not available, a combination of relatively selective antagonists can be employed to 
characterize the muscarinic receptor subtypes. In the present investigation, we used three 
such antagonists having different selectivity profiles, namely pirenzepine (1'vl[>M»M2)' 
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AF-DX 116 (M,>M,>M,) and HHSiD (M)~,»M,) (Doods et aI., 1994). However, it 
should be pointed out that the affinity values of these relatively selective antagonists 
obtained in the present experiments in the human myocardium are further prejudiced by the 
complex nature of acetylcholine response. 
7.5.2.1 Involvement of M, receptor subtype. The present study showed that AF-DX 
116, followed by HHSiD and pirenzepine) most effectively antagonized the atrial negative 
inotropic (figure 7.3) and ventricular positive inotropic (figure 7.4) effects of acetylcholine; 
the concentration-response curves were shifted to the right. The calculated apparent pKn 
values of AF-DX 116 in the atria (6.7±0.4) and ventricles (6.7±0.6) match with pK, values 
observed in the two tissues (7.14±0.06 and 7. I 8±0.06, respectively) for the displacement of 
['Hl-N-methyl scopolamine in guinea-pig membranes (Michel and Whiting, 1987). Thus, 
it appears that the muscarinic M, receptor subtype mediates both the negative (in atria) and 
positive (in ventricles) inotropic responses. This conclusion is in agreement with the 
demonstration of muscarinic M2 receptor mRNA and protein in human heart (Maeda et aI., 
1988; Caulfield, 1993). Moreover, it is now well established that the muscarinic M, 
receptor is coupled to three signal transduction pathways (Schimerlik, 1989): (i) inhibition 
of adenylyl cyclase to reduce cAMP (Fleming et aI., 1987), (ii) opening of potassium 
channels (Ray et aI., 1993) and (iii) hydrolysis of phosphatidylinosito1. The first two may 
contribute to the negative inotropic response of muscarinic receptor stimulation (Hanf 
et aI., 1993), while the third may induce positive inotropic responses (Mizushima et ai., 
1987; Kohl et aI., 1990). Although the exact molecular processes are unclear, it is believed 
that the two opposite functional responses are mediated via muscarinic M2 receptor coupled 
to different G-proteins and occurring in different states: a high affinity state associated with 
inhibition of adenylate cyclase and a low affinity state associated with the 
phosphatidylinositol breakdown (Brown and Brown, 1984). 
A recent study on comparison of muscarinic K+ chaillleis between human atrium and 
ventricle (Koumi et aI., 1994) showed that whole cell acetylcholine-induced K' current in 
human atria and ventricles exhibit substantially similar characteristics, with the exception of 
the channel density. Acetylcholinewinduced Kt current in atria was approximately two to 
three times higher than that ill ventricles. Another study on the comparison of coupling of 
muscarinic receptors in guinea·pig atrial and ventricular myocardium showed that atrial and 
ventricular receptors were similar, but receptor coupling to cyclase inhibition or 
phosphatidylinositol hydrolysis was distinguishable (Woodcock et aI., 1987). Thus, it is 
possible that all three pathways operate to mediate the observed tissue responses, but their 
importance may vary in different tissues andlor conditions. Based on the effect of 
acetylcholine on the baseline contractility (without prior stimulation with, for example, 
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noradrenaline), it would appear that the coupling of muscarinic M, receptors to adenylyl 
cyclase (negatively) and K+ chaIUlels may be more important in the atrial tissue, whereas in 
the ventricular tissue muscarinic M, receptors couple preferentially to phosphatidylinositol 
hydrolysis. However, it is possible that the coupling can alter in different conditions. 
Indeed, it is interesting to recall that in the human ventricular myocardium a 
concentration~dependent negative inotropic effect was seen after pre-stimulation with 
sympathomimetic agents (Jakob et aI., 1989; Landzberg et aI., 1994; present results). 
7.5.2.2 Involvement of muscarinic M, receptor subtype. Experiments with 
AF-DX 116 and HHSiD in atrial tissue showed that the positive inotropic effect of 
acetylcholine, observed with high concentrations and only when the atrial contractility had 
been depressed, was not attenuated and seemed to be potentiated by these compounds. On 
the other hand, pirenzepine seemed to attenuate this response, thereby accentuating the 
preceding negative inotropic effect (figure 7.3). It therefore appears that the 
acetylcholine-induced increase in depressed contractility is mediated by the muscarinic MI 
receptor subtype rather than the M, or M, subtype. Although HHSiD has been reported to 
be a more potent antagonist against M2 or M3 receptors (see Doods et aI., 1994), this 
apparently dose not seem to hold true for the human heart, where this compound blocked 
M2 receptor mediated responses (negative inotropism in atria and positive inotropism in 
ventricles) more effectively. 
The conclusion that the muscarinic M] receptor subtype mediates acetylcholine-
induced increases in atrial contractility is further substantiated by the results obtained with 
McN-A-343, which in the radioligand binding assays has similar affinities for the M\ and 
M2 receptor subtypes, but in functional assays, probably due to differences in intrinsic 
efficacy and/or tissue receptor reserve, shows selectivity for the muscarinic MI receptor 
subtype (Eglen et aI., 1987). Indeed, McN-A-343 failed to decrease atrial or increase 
ventricular contractility (figure 7.5)J thus ruling out activation of the muscarinic M2 
receptor subtype in the human heart. This compound, however, mimicked acetylcholine 
(higher concentrations) in increasing atrial contractility, once this had been depressed by 
prior administration of low concentrations of acetylcholine (figure 7.6). The reversal of the 
negative inotropic effect of acetylcholine by McN-A-343 cannot be due to a blockade of 
muscarinic M2 receptors, since the effect of McN-A~343 was antagonized by pirenzepine. 
The apparent pKB value of pirenzepine against McN-A-343 (8.57±O.33) was similar to the 
binding affinity of drug at the human cloned muscarinic M, receptor (pK,: 8.20±O.I3; 
Dorje et aI., 1991), thus confirming the involvement of muscarinic MI receptor subtype. 
Additional evidence for functional atrial muscarinic M] receptors comes from studies of 
Pitsschner and Wellstein (1988), who observed that low doses «3mg) of pirenzepine 
decrease heart rate in humans subjects. Similarly, the bradycardia caused by low doses of 
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atropine in humans may also be related to blockade of muscarinic M, receptors (Wellstein 
and Pitschner, 1988; present results), rather than central vagal stimulation (Weiner, 1990). 
Kellar et al. (1985) examined the binding of ['Hlacetylcholine and suggested that 
most of the muscarinic M, sites had a high affinity for acetylcholine, whereas the majority 
of muscarinic M] sites had a low affinity for acetylcholine. This is in agreement with our 
observations that the positive inotropic response in the atrial trabeculae was obtained with 
high concentrations of acetylcholine (10.4 or /0" M). It is possible that the muscarinic M, 
receptor mediating increases in atrial contractility is coupled to phosphatidylinositol 
hydrolysis (Gallo et aI., 1993; Wess et aI., 1993). 
In conclusion, the present investigation in the human isolated myocardium shows 
that: (i) in addition to the generally accepted negative inotropic effect, acetylcholine also 
causes positive inotropic effects at similar concentration in human ventricular trabeculae 
and both these responses are mediated by the muscarinic M, receptor subtype, possibly 
having preferentiai coupling to adenylyl cyclase (negatively) and K' channels in atria and 
to phospho inositol breakdown in ventricles, (ii) in trabeculae pre-stimulated with 
noradrenaline, acetylcholine elicited negative inotropic responses in both atrial and 
ventricular trabeculae, suggesting that the preferential coupling in the ventricles can be 
altered, and (iii) when atrial contractility has already been depressed, high concentrations of 
acetylcholine as well as McN-A-343 can increase the atrial contractility back towards 
baseline values via the muscarinic M, receptor subtype. The physiological relevance of the 
atrial muscarinic M] receptor is not yet clear. 
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Chapter 8 General discussion 
The studies presented in this thesis are composed of in vitro experiments studying 
pharmacological responses of isolated cardiac tissue. Three aspects make tlus thesis rather 
unique. 
i) The studies were performed on human cardiac tissue and, therefore, the results can be 
directly translated to the human situation without extrapolation from animal data. 
Nevcl1heless, some studies were performed in porcine cardiac tissue in parallel to 
evaluate this species as a model for human tissue. 
ii) The studies were performed in human healthy (without cardiac diseases) atrial and 
ventricular tissue, which, especially the latter, is difficult to obtain on a regular basis. 
The results provide information about the regulation of contractility in human cardiac 
muscle in non·diseased slales, 
iii) The studies were performed on right atrial and left ventricular tissues obtained from 
the same heart. The results may represent the different contribution of the atrium and 
ventricle to overall function of the heart. The use of the atrial and ventricular tissue 
in parallel enhances the value of comparison of the responses. of the two tissues with 
regard to their function in vivo. 
The present chapter discusses the results with respect to comparison of human and 
porcine heart, atrial versus ventricular tissue responses, and receptor subtypes mediating the 
responses. 
8.1 Spccies differences 
The lise of laboratory animals as models for man provides an important and 
convenient method for pharmacological research. However, for such an approach to 
succeed, it is imperative that chosen animal species does not show species·related 
differences with human pharmacology. For evaluation of porcine cardiac tissue as a 
model, in some of our studies the differences and similarities of the porcine and human 
tissue in contractile responses are discussed. 
8.1.2 Differelll respollse 
In chapter 5, we showed that human a-CORP exerted different effects, presumably 
through the same receptor, on porcine and human hearts. a-CORP induced a positive 
inotropic response in porcine ventricular, but not in atrial trabeculae. In contrast, a-CGRP 
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increased the contractility in human atrial, but not in ventricular trabeculae (chapter 6). It 
is known that positive inotropic effect of human CORP in most species is mediated by 
specific CORP receptors coupled to adenylyl cyclase (Franco-Cereceda et aI., 1987; 
Miyauchi et aI., 1987; Ono et aI., 1989; Anand et aI., 1991). We do not know whether the 
different responsiveness of human and porcine myocardium is due to the use of human 
CORP in both human and porcine heart or to a different distribution or type of functional 
CORP receptors in the two species. Specific binding sites for CORP have been 
demonstrated in porcine ventricular tissue (Miyauchi et aI., 1988) and rat atrium (Sigrist et 
aI., 1986), whereas for porcine atrial and human cardiac tissue this is not known, 
The above observation showed, probably for the first time, that a biogenic substance 
induces a positive inotropic response in a mammalian ventricular tissue without a 
corresponding effect in atrial tissue. The opposite has been shown with several substances 
in the heart from several species (Ziogas et aI., 1985; Schoemaker et ai, 1992, 1993; 
Feolde et aI., 1993; Du et aI., 1994; Ishihata et aI., 1995). The results of this study suggest 
that the response to an endogenous substance could be species-specific as it induces 
different responses in different species. 
8.1.3 Similar response bill different receplors 
In chapter 4, we showed that histamine induced a similar response in different species 
mediated by different receptor subtypes. Histamine produced a positive inotropic effect in 
human atrial and ventricular trabeculae as well as porcine atrial trabeculae via histamine H2 
receptors. In porcine ventricular trabeculae, histamine induced a similar response, 
however, via histamine HI receptors. This receptor subtype difference is not unique for the 
porcine heart and it occurs in other species as well. For instance, the positive inotropic 
effect of histamine in dog atrium (Chiba et aI., 1977) as well as in guinea pig left atrium 
(Verma and McNeill 1977) is due to stimulation of HI receptors. On the other hand, in 
rabbit ventricular muscle, the effect is mediated by both HI and H, receptors (Elizalde, 
1986). Similarly, as reviewed by Saxena and Villal6n (1991), cardiac stimulation by 5-HT 
is mediated by 5-HTJ-like, 5-HT2, 5-HTJ and 5-HT.j receptors in, respectively, the cat, rat, 
rabbit and pig; however, in this case, porcine and human heart resemble each other. Thus, 
according to the resuits described in this thesis (see chapter 4 and 5), we conclude that 
porcine cardiac tissue, although pharmacologically similar in several respects, is still 
distinguishable from that of humans, indicating that the porcine heart model too has its 
limitation. Although animal models may provide a useful tool for answering specific 
questions, an evaluation of interference of species-related differences with regard to 
pharmacologic regulation of cardiac contractility is necessary. Therefore, we restricted 
further experiments to only human tissue. 
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8.2 Different response in human atrial and ventricular tissue 
Focusing on human atrial and ventricular tissue, we found that biogenic substances 
could induce similar or different responses in atrial and ventricular tissue from the same 
heart, A parallel experiment in atrial and ventricular tissue is necessary for studies on 
cardiac contractility. 
8.2.1 Differenl response bul similar receplor 
Chapter 7 showed that a biogenic substance can induce different responses in atrial 
and ventricular tissue mediated by the same receptors. Acetylcholine (:>10·' M) produced a 
negative inotropic effect in human atrial trabeculae, but a positive inotropic effect in 
ventricular trabeculae; both effects were mediated by M2 muscarinic receptors. It is well 
known that M2 receptors are coupled to multiple second messenger systems (Schimerlik, 
1989): 1. Inhibition of adenylyl cyclase to reduce cAMP and opening of potassium 
channels, which may contribute to the negative inotropic response of muscarinic receptor 
stimulation (Hanf et aI., 1993); 2. Stimulation of phosphoinositide hydrolysis, which may 
be responsible for the positive inotropic effect of choline esters (Korth et aI., 1987). The 
difference in atrial and ventricular response may be explained by coupling of the M, 
muscarinic receptor to different second messenger systems: in atrial tissue, the M2 receptor 
may couple predominantly negatively to the cAMP pathway, whereas in ventricular tissue, 
the M, receptor may couple mainly to the IP, pathway. The above observations provide a 
clear example that, although both tissues were taken from the same heart, the results from 
atrial tissue are not representative for the rest of the heart, including ventricular tissue. 
The difference in atrial and ventricular tissue is further discussed below. 
8.2.2 Lack o/venlricular response 
At the beginning of the prescnt studies (chapters 2 and 3), we observed that atrial and 
ventricular trabeculae from the same human heart showed different response to 5-HT: 5-HT 
induced a positive inotropic effect in atrial but not in ventricular tissue. Similar results 
were obtained in porcine heart. The effect of 5·HT in atrial tissue is mediated by 5·HT4 
receptors coupled to the adenylyl cyclase IcAMP second messenger system (Kaumann et 
aI., 199Ia,b). The results have led to two questions: 1. Is this phenomenon unique for 
5-HT or could it be observed for other substances as well? 2. Why does ventricular tissue 
fail to respond to this and other substances? 
\Vith regard to the first question, our results (chapter 6) showed that other substances, 
including human a-CORP and angiotensin II, increased atrial, but not ventricular 
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contractility. Moreover, substances that decrease cardiac contractility (adenosine and 
somatostatin) affected atrial tissue, but they were virtually inactive in ventricular tissue. 
We, therefore, conclude that the effect of 5-HT with regard to the different atrial and 
ventricular responses was not limited to 5-HT, but could also be observed with other 
substances. Atrial tissue may be more sensitive to endogenous inotropic substances than 
ventricular tissue. 
Based on our studies, a clear explanation for the different responses of atrial and 
ventricular trabeculae (question 2) is difficult to give. Obviously, the force of contraction 
of ventricular tissue can be increased by positive inotropic agents, since this tissue showed 
a substantial response to noradrenaline and histamine (chapter 4). Because both 
noradrenaline and histamine exert their positive inotropic effect by increasing cAMP levels 
through adenylyl cyclase stimulation, we conclude that this pathway was intact in our 
preparations. However, in contrast to atrial tissue, ventricular tissue did not respond to 
angiotensin II, human a-CORP, adenosine and somatostatin. Since 5-HT, a-CORP, 
adenosine and somatostatin all act via their receptors coupled to the adenylyl cyclase 
pathway, which, as argued above, seems to function normally, the lack of response in 
ventricular tissue may be caused by either a too low receptor number or by receptors that 
are not coupled to their signal transduction pathway. Moreover, this lack of ventricular 
response is not restricted to substances acting via adenylyl cyclase/cAMP pathway, since it 
was also observed for angiotensin II, that acts via the PLC/IP,tDG pathway, 
For at least some substances, there is evidence for reduced receptor density or 
different receptor subtype in ventricular tissue, In a recent review, Kauma'lli (1994) 
suggested that functional 5-HT.J receptors may be absent in human ventricular myocytes, 
Nozawa et al. (1994) suggest that, in contrast to human atrial myocardium with mainly 
AT I receptors, the predominant angiotensin II receptor subtype in human ventricular 
myocardium is AT2, which does not modulate contractility. Thus, in addition to a 
difference in receptor density between atrial and ventricular tissue, the different subtypes of 
angiotensin II receptors may also contribute to the lack of ventricular response. Specific 
binding sites for CGRP were identified in high concentration in rat atrium, but very few 
were found in guinea pig ventricles (Sigrist et al. , 1986; Ishikawa et aI., 1988). Since the 
response in rat and guinea pig cardiac tissue is similar to that in human tissue, this 
explanation may also be true for the human heart. In human atrial tissue, the density of 
adenosine AI receptors is about twice as high as in the ventricle (Bolun et al., 1989). 
These data may explain the lack of response with adenosine in human ventricular tissue. 
The above results show that atrial contractility is more sensitive to several 
cardiovascular relevant endogenous substances than ventricular contractility. This 
observation may have important implications for drug development. Usually. development 
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of therapeutic agents that influence cardiac contractility is directed to increase ventricular 
contractile force, as it is a major determinant of left ventricular function. In this regard, 
the use of atrial tissue as representing l1cardiac tissue" is questionable and can be 
tnisleading. On the other hand, since atrial tissue seems more sensitive to most of the 
substances investigated so far, the contribution of atrial contraction to the overall cardiac 
function may have been generally underestimated. 
8.2.3 Functional importance 
Data from this thesis showed that ventricular tissue from both man and pig did not 
respond to several positive inotropic substances. Also some negative inotropic substances, 
acetylcholine, adenosine and somatostatin, decreased force of contraction only in atrial, but 
not in ventricular tissue. In vivo, under normal conditions, the atrial contraction causes an 
additional 30% of filling of the ventricle, which is normally not really needed because of 
the 300·400% overcapacity of heart (Guyton, 1986). However, under pathological 
conditions such as myocardial infarction, when cardiac reserve has decreased, the 
contribution of atrial contraction to ventricular filling increases to 42% (Matsuda et aI., 
1983). The atrial contraction contributes by about 35% to the stroke volume after 
myocardial infarction, compared to 22% under normal conditions. Thus, although atrial 
contraction under healthy conditions may not be important for cardiac function, its 
contribution becomes more significant in pathological condition. 
It is interesting to notice that a direct negative inotropic response on baseline 
ventricular contractility was not detected with any of the biogenic substances studied here. 
The present results and those from other laboratories have shown that in mammalian 
ventricular tissue, a negative inotropic response can only be observed after pre~stimulation 
with catecholamines (B6lml et aI., 1985; 1988; Endoh et aI., 1985), though a direct 
negative inotropic effect of carbachol (a muscarinic agonist) has been reported in chick 
ventricular muscle strips (Sorota et aI., 1986). These results suggest that left ventricular 
tissue, at rest, can only be stimulated, but not depressed by biogenic substances, If these 
results from in vitro studies can be extrapolated to the in vivo situation, it would suggest 
that a lowering in left ventricular contraction can only be obtained indirectly by reduction 
of atrial contractility and, hence, ventricular filling, Enhanced left ventricular contraction 
could be obtained either directly via O-adrenergic stimulation, histamine and, surprisingly, 
acetylcholine or indirectly by increasing atrial contraction via substances, such as a-CGRP, 
angiotensin II and 5-HT. 
On the basis of the results, we can only speculate about the physiological meaning of 
the atrial-ventricular differences. It is possible that atrial contractile force is regulated 
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more subtly than that of ventricles, and relatively small changes in left ventricular filling 
affect left ventricular function via the Frank Starling mechanism. Only in case of 
pronounced extra need for cardiac output, for instance, during sympathetic stimulation, the 
ventricle itself is stimulated to enhance contractile force, with concomitant extra energy 
costs. Since all experiments were performed in nonKdiseased cardiac tissue, the outcome 
may be different in pathological conditions where direct ventricular stimulation is needed 
for sufficient cardiac output. 
Further investigation may provide a better understanding of the physiology of atrial 
and ventricular contractility, from which dmg development can benefit. 
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Summary 
The first purpose of the present thesis was to investigate the effects and the possible 
mechanisms of several biogenic substances (5~HT, histamine, human a-CORP, 
angiotensin II, adenosine, somatostatin and acetylcholine) in human isolated myocardium, 
although some studies were performed on porcine heart to evaluate this as a model for 
human heart. Myocardial contractility, as the major parameter of the function of the heari, 
has been studied in different situations. In vivo, the changes in force of contraction in the 
heart can be markedly influenced by reflex mechanisms as well as hemodynamic changes. 
Therefore, isolated, electrically driven cardiac preparations provide a useful model to 
examine the direct effects of substances on cardiac contractility. Since endogenous 
substances are associated with the physiologic and pathophysiological changes in human 
body, pharmacologic investigations on cardiac contractility in isolated myocardium can 
provide useful information for developing better drugs. From our studies on the inotropic 
effects of several biogenic substances, it is interesting to notice that different 
pharmacologic responses were observed not only in different species, but also in atrial and 
ventricular tissue from the same heart. 
The second aim of our study was to explore the differences in the pharmacology of 
human isolated atrial and ventricular trabeculae. Evidence shows that atrium and ventricle 
may play different roles in the regulation of cardiac contractility. To distillguish between 
atrial and ventricular responses, these tissues should be studied separately, but in parallel, 
implying in vitro methods. 
Species-related pharmacologic differences were observed in functional responses as 
well as receptor subtypes. The difference in the functional response is exemplified by the 
effects of human «-CORP in human and porcine isolated myocardium (chapter 5 and 6). 
Human a-CORP induced a concentration-dependent positive inotropic response in human 
atrial but not in ventricular trabeculae. In contrast, in porcine heart, the human a-CORP 
induced a positive inotropic effect in ventricular but not in atrial trabeculae. Furthermore, 
the effects of histamine provide a good example for the species-related receptor subtype 
dissimilarity. Histamine (chapter 4) increased the contractility in both human and porcine 
myocardium. However, the effects of histamine in human atrial and ventricular trabeculae 
as well as in porcine atrial trabeculae were mediated by H2 histamine receptor. In contrast, 
the effect in porcine ventricular trabeculae was mediated by HI histamine receptor. This 
data indicated that a similar response in atrial and ventricular tissues could be mediated by 
different receptors. Our results obtained from porcine isolated myocardium showed similar 
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responses and mechanisms in most cases when compared to human myocardium. 
However, also dissimilar, substantiated by responses to human a-CORP as well as to 
histamine with human tissues were observed) suggesting that this model, too, has its 
limitations. 
An important aspect of this thesis is that atrial and ventricular tissues obtained from 
the same heart showed differences. Firstly, baseline contractile force was significantly 
lower in the atrial than in ventricular tissue in both hwuan and porcine myocardium. This 
difference is compatible with the different ill vivo function of these two parts of the heart. 
Secondly, the pharmacological differences of these two tissues concerned both functional 
responses, receptor subtypes and coupling. As shown in chapter 2 and 3) it was found that 
5-HT increased the force of contraction in atrial trabeculae from human and pig in 
concentration-dependent marmer, but, it failed to affect the force of contraction in 
ventricular trabeculae from both species. Similar to 5-HT, several other substances 
including human a-CORP and angiotensin II also caused concentration-dependent increases 
in force of contraction in human atrial (chapter 6), but not in human ventricular trabeculae. 
Moreover, not only positive inotropic substances, also some negative inotropic substances 
were virtually inactive in modifying the baseline ventricular contractility. Adenosine and 
somatostatin (chapter 6) induced a concentration-dependent negative inotropic effect on 
baseline human atrial contractility, but no response was found on baseline human 
ventricular contractility. Adenosine, but not somatostatin, reduced force of contraction 
after pre-stimulation with 10-' M noradrenaline in atrial tissue and, to a lesser extent, in 
ventricular tissue. 
Different responses of atrial and ventricular tissue can also be observed with 
acetylcholine, which elicited a biphasic inotropic effect (an initial decrease followed by an 
increase in contractility back to baseline values) in human atrial trabeculae, whereas, only a 
positive inotropic effect was observed in the ventricular trabeculae (chapter 7). It was 
interesting to discover that the negative inotropic effect of acetylcholine (,;10" M) in atrial 
trabeculae and the positive inotropic effect of acetylcholine in ventricular trabeculae were 
mediated by the same M2 muscarinic receptor. Under conditions of raised contractility 
achieved by exposure to noradrenaline (10-' M), negative inotropic effects, mediated by M2 
muscarinic receptor too, were observed in both atria and ventricles. However, our results 
suggest that the positive inotropic effect of acetylcholine (lO-' to 10-) M) in the atrial 
tissue, observed only in preparations with depressed contractility, was associated with M] 
receptor stimulation. From this study, we can conclude that a different response in atrial 
and ventricular tissue could even be mediated by the same receptors. 
The data from the present thesis indicate that force of contraction in atrial tissue can 
be affected by either positive or negative inotropic substances, whereas in ventricular 
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tissue, only positive inotropic effects could be detected on baseline contractility. Atrial 
tissue appeared to be more sensitive to endogenous inotropic substances than ventricular 
tissue. Since atrial and ventricular tissues display different responses to above biogenic 
substances, a different mechanism of regulation of contractility seems feasible. If these 
results from in vitro studies can be extrapolated to the in vivo situation, the contribution of 
atrial contractility to overall cardiac function may be generally underestimated. Our results 
may provide a better understanding of the physiology of atrial and ventricular contractility, 
from which drug development can benefit. 
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Samenvatting 
Het hart is cen van de vitale organen in het menselijk lichaam en hart en vaatziekten 
zijn al gauw levensbedreigend. Onderzoek naar de effecten van geneesmiddelen zijn dan 
ook erg belangrijk. Het gebruik van menselijk weefsel daarbij is uiterst beperkt. Soms 
kan tijdens operaties (bv. by-pass) een stukje atrium verkregen worden dat gebruikt kan 
worden voor onderzoek. Resultaten verkregen m,b.v. dit stukje weefsel worden vaak 
geextrapoleerd naar het hele hart, inclusief het voor de functie zo belangrijke linker 
ventrikel. 
Het eerste doe I van dit proefschrift was de effecten van verscheidene endogene 
stoffen te bestuderen op humaan gersoleerd hartspierweefsel. Tevens zijn enkele van de 
studies oak uitgevoerd op hartspierweefsel van varkens, am dit als model voor humaan 
hartweefsel te evalueren. Ge'isoleerde, elektrisch gestimuleerde trabeculea vormen cen 
praktische opstelling voor studies naar effecten op contractiekracht zonder de invloed van 
reflex mechanismen en wisselende hemodynamische en neurohumorale invloeden. 
Species gerelateerde verschillen werden gevonden in de response zelf en in de 
receptoren betrokken bij de response. Een species-verschil in response is gevonden bij 
humaan «-CORP (hoofdstuk 5 en 6), hetgeen in menselijk materiaal een positief inotrope 
response gaf in atriaal, maar niet in ventriculair weefsel. Voor de varkensharten werd het 
omgekeerde gevonden. Histamine daarentegen (hoofdstuk 4) gaf in atrium en ventrikel 
weefsel van zowel mens als varken cen vergelijkbare response. Echter de receptoren 
betrokken in deze response waren in menselijk atrium en ventrikel, en in varkens atrium de 
H2, en in varkensventrikcl de HI receptor. Dus ondanks overcenkomsten in reacties zijn er 
ook verschillen aan te tonen in varkensharten t.o.v. mensenharten, hetgeen aangeeft dat ook 
dit model zo zijn beperkingen kent. 
Ui( de studies naar inotrope effecten van endogene stoffen kwamen niet aileen 
species-verschillen naar voren maar ook verschillen in reacHes van atriale en ventriculaire 
trabeculae uit het zelfde hart. 
Het tweede doel van dit proefschrift was deze atrium/ventrikel verschillen verdcr te 
onderzocken. Beide delen van het hart hebben een verschillende bijdl'age aan de totale 
hartfunctie en dam'om mogelijk ook een verschillende regulatie van de contractiliteit. Om 
atrium en ventrikel weefsel apart te onderzoeken is een in vitro benadering noodzakelijk. 
Het verschil tussen atriale en ventriculaire reacties vormt een belangrijk aspect van dit 
proefschrift. Allereerst was de basale contractiekracht van atriale trabeculae lager dan die 
van ventriculaire trabeculae. Dit is compatibel met de verschillen in in vivo functies van 
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de beide delen. In hoofdstuk 2 en 3 wordt aangetoond dat serotonine wei een positief 
inotroop effect op atriaal weefsel heeft, maar niet op ventriculair weefsel. Deze observatie 
is niet beperkt tot serotonine; ook CGRP en angiotensine II laten dit zien (hoofdstuk 6). 
Niet aileen positief inotrope stoffen maar ook negatief inotrope stoffen, zoals adenosine en 
somatostatine (hoofdstuk 6) gaven weI response in atriaal, maar niet in ventriculair weefsel. 
Naast een afwezigheid van reactie in ventriculair weefsel is ook een verschillende 
reacties van ventriculair t.o.v. atriaal weefsel gevonden voor acetylcholine; in atrium een 
bi-fasisch effect (eerst negatief inotroop en bij hogere concentraties terug naar de 
uitgangswaarde) en in het ventrikel aIleen een positief inotroop effect (hoofdstuk 7). 
Verrassend was dat en het negatief inotrope effect in atriale trabeculae en het positief 
inotrope effect in ventriculaire trabeculae door dezelfde M2 receptoren gemedieerd worden, 
doch gekoppeld aan verschillende second messenger system en. Het positief inotrope effect 
bij hoge concentraties in atriaal weefsel bleek gemedieerd door MI receptorell. Vit deze 
experimenten hebben we geconcludeerd dat een verschillende response in atriaal en 
ventriculair weefsel terug te voeren kan zijn op verschillen in receptordichtheid, 
receptorsubtype en zelfs gemedieerd kan worden door hetzelfde receptorsubtype, maar 
verschillend gekoppeld. 
De data in dit proefschrift suggereren dat de contractiekracht in atrieel weefsel 
be'invloed kan worden door zowel positief ais negatief inotrope stoffen, terwijl ventriculair 
weefsel aIleen reageert op positief inotrope invloeden. Het atrium lijkt meer gevoelig voor 
endogene inotrope invloeden dan het ventrikel. Indien de resultaten van deze in vitro 
studies kunnen worden geextrapoleerd naar de in vivo situatie, dan kunnen ze een 
belangrijke bijdrage leveren aan het inzicht in de regulatie van contractiliteit en hartfunctie. 
Een inzicht waar de ontwikkeling van geneesmiddelen zijn voordeel mee kan doen. 
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